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Abstract 
Our lab has discovered a novel protein which has been shown to cleave c-myc 
mRNA within the coding region determinant (CRD). This protein was tentatively 
identified as Syntaxinl8, a known t-SNARE protein. Recombinant Syntaxinl8 has been 
shown to possess endoribonucleolytic activity against c-myc mRNA in vitro. In order to 
determine whether Syntaxinl8 functions as an endoribonuclease in cells, the effect of 
altering its expression on the proliferation, levels and stability of c-myc mRNA was 
examined. 
Through Western analysis, it was discovered that the expression of Syntaxinl8 
was similar in all immortalized cancer cell lines examined. However, higher Syntaxinl8 
expression was observed in cancerous breast tissue when compared to the normal breast 
tissue. MTT assays and ribonuclease protection assays revealed that modulation of 
Syntaxinl8 had an effect of the proliferation of cells; however, this did not seem to occur 
through an endoribonucleolytic mechanism. 
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CHAPTER 1 - INTRODUCTION 1 
Chapter 1 
Introduction 
Gene expression is controlled at multiple levels within any organism. 
Transcriptional, post-transcriptional and translational controls are essential to maintain 
proper gene expression. This thesis focuses on examining the significance of post-
transcriptional control, namely mRNA degradation, in the regulation of gene expression. 
One class of enzymes, termed endoribonucleases, has the ability to silence genes at the 
post-transcriptional level. Endoribonucleases are an important class of enzymes in 
regards to mRNA degradation. They can cleave transcripts, thereby silencing them and 
changing expression of the gene. This review will describe mechanisms of mRNA 
degradation, and several known vertebrate endoribonucleases. The protein that is the 
focus of this study, Syntaxin 18, will also be reviewed. 
1.1. Post Transcriptional Regulation of Gene Expression 
This study will focus on a candidate mammalian endoribonuclease that has been 
shown to cleave mRNA in vitro. As such, it is important to discuss mRNA degradation 
and proteins that have been known to affect mRNA degradation. 
Gene expression is a multi-step process involving many types of regulatory 
mechanisms. Regulation ensures that important genes are expressed at appropriate levels 
under basal conditions, while other genes are silent under certain conditions. From 
genomic DNA, an intermediate molecule is produced. This molecule is called messenger 
RNA, and it is made up of a ribonucleotide sequence that codes for a specific protein. 
Proteins are translated from a single mRNA within polysomes. There must exist 
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mechanism(s) in cells that subject mRNAs to degradation when the protein is no longer 
required. In fact, when an mRNA molecule is in the cytoplasm it can potentially be 
degraded, and the rate at which this happens is dependant on the stability of the mRNA 
(Russell. 2002; Audic et al. 2004). The mRNA molecule can be quite stable, such as fi-
globin mRNA, which has a half-life greater than 10 hours. Conversely, many are 
relatively unstable and have half-lives of less than 30 minutes, as is the case for many 
transcription factors such as the mRNA for c-myc (Alberts et al. 2002; Ross, 1995). 
mRNA half-life is influenced by many factors such as environmental changes and 
physiological requirements. Messenger RNA stability in turn can affect many cellular 
processes. Therefore, mRNA stability is essential to the ability of organisms to develop 
and respond to their environment. When the mRNA of a tightly regulated gene is more 
stable than normal, an exaggerated amount of protein could be produced because the 
translation machinery has more time to generate the protein. This can be seen in genetic 
diseases such as cancer. In some tumors, mRNA's that encode oncogenes are stabilized, 
resulting in exaggerated protein production and uncontrolled cellular division (Audic et 
al. 2004). Therefore, it is essential that the post-transcriptional regulation of certain 
mRNAs be tightly regulated in order to avoid certain detrimental pathological states. 
1.1.1. Messenger RNA degradation 
Messenger RNA degradation is a form of post-transcriptional regulation that is 
performed by both prokaryotes and eukaryotes, including mammals (Ross et al. 1995; 
Takayama et al. 2000; Codon. 2003). It is not as well understood as transcriptional 
regulation, but it is gaining recognition as an important method to control gene 
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expression (Takayama et al. 2000; Guhaniyogi et al. 2001; Brewer. 2002). Messenger 
RNA turnover functions, along with other forms of gene regulation, to allow the cells to 
rapidly respond to changes in the environment (Ross et al. 1995; Takayama et al. 2000). 
Also, mRNA turnover is important for proper gene expression during the development of 
an organism because it allows tight regulation of cytokines and transcription factors 
essential for cellular proliferation and differentiation (Alberts et al. 2002; Brewer. 2002). 
The rate of mRNA degradation is dependant on the half-life of the particular mRNA 
molecule. Changing mRNA stability allows cells to fluctuate the half-life to increase or 
decrease the rate of degradation as necessary. If the half-life of a particular mRNA in 
changed, the amount present in the cytoplasm can change many-fold while transcription 
rates remain constant (Ross. 1995). 
Messenger RNA turnover is dependant on interaction between trans-acting 
enzymes, RNA-binding proteins and cis-elements within the mRNA molecule. For 
example, in the prokaryote Escherichia coli, mRNA degradation is facilitated through the 
removal of fragments from the full length transcript by endonucleolytic cleavages in the 
5' to 3' direction. These fragments are then digested exonucleolitycally in the 3' to 5' 
direction (Nicholson. 1999; Coburn et al. 1999). This process is carried out by a group of 
ribonucleases, and can be affected by cis-elements on the transcript itself. These 
enzymes and elements will be discussed later in this review. 
Eukaryotic mRNA is processed after transcription. This includes the addition of a 
5'-methylated cap and a poly-adenylated (poly(A)) tail (Alberts et al. 2002). Once in the 
cytoplasm, mRNA can be degraded by one of two mechanisms. The first involves a 
gradual shortening of the poly(A) tail, followed by decapping at the 5'end and rapid 5' to 
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3' and 3' to 5' degradation (Alberts et al. 2002; Decker et al. 2002). The second 
mechanism involves cleavage by an endonuclease followed by decapping at the 5'end 
and rapid 5' to 3' and 3' to 5' degradation (Russell. 2002; Alberts et al. 2002). Both of 
these mechanisms involve ribonucleases that work to ultimately reduce the mRNA 
molecule to individual mononucleotides (Figure 1). 
(A) 3' UTR 
c a ? c<^l!!}£^9i!£.nce»_J_ 
5''Qn;w:;»^:^a«a«#*#tczzz)AAAAA.~200 3' 
SLOW I poly-A shortening 
decapping , v 3 ' to 5' 
fo
'Sd3'by / degradat ion 
degradation / F A S T \ 
=iA~30( 
(B) endonucleolytic 
cleavage site 
I endonucleolytic cleavage 
5'C 
decapping 
followed by / \ 3' to 5' 
5' to 3" / \ degradation 
degradat ion / FAST 
Figure 1. Two mechanisms for mRNA degradation. Mechanism (A) 
shows a gradual shortening of the poly(A) tail followed by de-capping 
of the 5' end an rapid degradation. This illustrates the importance of 
poly(A) length because there is a fast rate of degradation after the tail 
reaches a threshold of about 30 nucleotides. Mechanism (B) shows 
cleavage in the middle of the molecule by an endoribonuclease (see c-
myc CRD below). This is followed by de-capping and rapid 
degradation. This figure was adapted from Alberts et al, 2002. 
The mechanisms described above are highly non-specific, therefore many 
unstable mRNA contain additional regulatory elements within their nucleotide sequences 
to help increase or decrease the likelihood of degradation (Alberts et al. 2002; Audic et 
al. 2004; Ross et al. 1995). One such regulatory element is the AU-rich element (ARE). 
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AREs are found in the 3' un-translated region of the mRNA, and they have been linked to 
mRNA instability (Barreau et al. 2005; Audic et al. 2004; Guhaniyogi et al. 2001). For 
example, the mRNA of c-fos, a transcription factor, contains an ARE which targets the 
molecule rapid for deadenylation and consequently the whole mRNA is degraded rapidly 
(Audic et al. 2004). Other mRNAs that have AREs are c-myc, c-jun, MMP-13, 
cyclooxygenase, and various cyclin transcipts (Lee et al. 2006; Audic et al. 2004; Ross et 
al. 1995). All of these genes are under tight regulation and can contribute to 
carcinogenesis if expression is abnormal (Audic et al. 2004). 
Another cis acting element that can be found in a select group of mRNA's is the 
coding region determinant (CRD). The CRD is an instability determinant that functions, 
through interaction with trans-acting proteins, to modulate the stability of the rest of the 
mRNA molecule. An example can be seen in the mRNA of c-fos. C-fos contains a CRD 
that binds a complex that protects the poly(A) tail from being shortened. However, once 
the gene in translated, members of the complex are removed and the mRNA is tagged for 
rapid degradation (Audic et al. 2004). Also, functioning through a different mechanism, 
the mRNA of the proto-oncogene c-myc contains a CRD which is the site of competition 
between an endonuclease and a protective binding protein (Audic et al. 2004; Lee et al. 
1998). This interaction will be discussed in detail later in this review. 
1.1.2. Messenger RNA binding proteins 
The life span of an mRNA depends on its interactions with various proteins. 
These mRNA binding proteins are necessary for processing, transport, translation and 
degradation of the mRNA (Audic et al. 2004; Ross. 1995; Niessing et al. 2004; Cosson et 
al. 2004; Siomi et al. 1993). 
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Messenger RNA binding proteins that regulate stability can either work as a 
stabilizing or a destabilizing factor. One mRNA binding protein that can function to 
regulate stability is the poly(A)-binding protein (PABP) (Alberts et al. 2002; Khanna et 
al. 2004; Bernstein et al. 1989). The PABP acts to stabilize mRNA by protecting it from 
rapid deadenylation (Bernstein et al. 1989; Ross. 1995). It also associates with the 5' cap 
and adjacent nucleotides and protects it from hydrolysis and consequent 5' to 3' 
degradation (Khanna et al. 2004). Another example of how the PABP can modulate 
stability can be seen in the mRNA of the proto-oncogene c-fos. The CRD in c-fos serves 
to bind a complex consisting of at least five proteins, one of which is the PABP. This 
complex bridges the 3' and 5' ends of the mRNA, which protects the poly(A) tail from 
rapid degradation. When the mRNA is translated, the complex is removed from the CRD 
but is still associated with the mRNA. This tags the c-fos mRNA for rapid poly(A) 
shortening and degradation (Grosset et al. 2000; Ross. 1995). 
Another stabilizing protein that binds mRNA is the translation initiation factor 
eIF4E. This protein binds to the 5'-methylated cap and protects it from being removed 
(Guhaniyogi et al. 2001; Ptushkina et al. 1999). This will stabilize the mRNA because it 
will prevent the decapping that is necessary for 5' to 3' degradation. 
Other important RNA binding proteins that can affect stability are AU-rich 
element binding proteins (ARE-BP). Three ARE-BPs have been identified to regulate 
mRNA stability of proto-oncogenes and cytokines. HuR protects ARE containing 
mRNA from rapid degradation while tristetraprolin (TTP), and another protein termed 
AUF1 act as destabilizing factors (Sarkar et al. 2003; Lu et al. 2004). Also, KH-type 
slicing-regulatory protein (KSRP) promotes ARE mediated degradation (Lu et al. 2004; 
CHAPTER 1 - INTRODUCTION 7 
Chen et al. 2001). It has been shown that HuR and AUF1 have similar tissue 
distribution, and it is thought that it is the ratio of one to the other that determines the 
stability of the target mRNA (Lu et al. 2004). 
Another mRNA binding protein that is important to the stability of c-myc mRNA 
is the protective CRD-binding protein, or CRD-BP. CRD-BP will be discussed in greater 
detail in the section 1.1.4 of this review. 
1.1.3. Exoribonucleases and Endoribonucleases 
The breakdown of all types of RNA, including rRNA, tRNA and mRNA, is 
mediated by both exoribonucleases and endoribonucleases. To date, there have been 
ribonucleases identified in bacterial, yeast and mammalian cells (Decker et al. 2002; 
Nicholson. 1999; Guhaniyogi et al. 2001). In E. coli, the major pathway of degradation 
involves a multi-protein complex called the degradasome. The degradasome contains an 
endonuclease called RNaseE and an exonuclease called polynucleotide phosphorylase 
(PNPase) (Condon. 2003; Coburn et al. 1999). The major pathway of degradation in 
yeast occurs in the 5' to 3' direction and involves an exonuclease called Xrnlp. Another 
non-specific mRNA decay pathway in yeast involves a complex of ten exonucleases 
called the exosome (Decker et al. 2002; Chen et al. 2001). This particle facilitates the 3' 
to 5' decay of yeast mRNA and is conserved in more complex eukaryotes, including 
mammals (Chen et al. 2001). No endonuclease activity has been observed in yeast so it 
does not appear to be a significant pathway for mRNA turnover (Wilusz et al. 2001). 
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The catabolism of mRNA in mammalian cells has been shown to be a 
combination of both exonucleolytic and endonucleolytic activity. As mentioned above, 
the exosome is conserved in mammalian cells and facilitates the 3' to 5' decay of target 
mRNA (Chen et al. 2001). Also, another exoribonuclease called deadenylating 
ribonuclease (DAN) has been discovered to have activity in human cells. This enzyme 
works to shorten the poly(A)-tail which will result in decapping and exonuclease activity 
in each direction (Mitchell et al. 2000). XRN1 is the major cytoplasmic exonuclease that 
functions in 5' to 3' decay of mRNA. This endonuclease is contained in highly enriched 
foci within the cytoplasm where it is thought to function in mRNA decay (Bashkirov et 
al. 1997). There is evidence that endonucleases are also important in vertebrate mRNA 
decay pathways (outlined in Table 1). Degradation intermediates and endonuclease 
products have been observed for various RNA molecules including transferin receptor, 
9E3, IFG-II, apolipoprotein II, albumin, c-myc, vitellogenin, a-globin and fi-globin 
(Rogers et al. 2002; Wang et al. 2000; Yang et al. 2004). 
Enzymes that catalyze the cleavage of these transcripts remain largely elusive; 
however, there is evidence to support the identity some candidate proteins that may 
function in mRNA turnover. An endonuclease, termed polysomal ribonuclease-1 (PMR-
1) has been identified in Xenopus. PMR-1 mediates endonucleolytic cleavage of mRNA 
which results in rapid degradation of the cleaved mRNA. PMR-1 has been shown to 
cleave Xenopus albumin and vitellogenin mRNA (Cunningham et al. 2000; Yang et al. 
2000). Also, when the cDNA for a possible human endoribonuclease, ARD-1, is 
transformed into E.coli cells, it acts to cleave all the same substrates as the bacterial 
endonuclease RNase E, including many mRNAs (Claverie-Martin et al. 1997). Another 
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candidate endonuclease is erythroid-enriched endoribonuclease or ErEN has been shown 
to cleave a-globulin mRNA within its 3'-UTR. This cleavage can also be inhibited by 
the presence of the trans factor poly(A)-binding protein (Wang et al. 2000; Rogers et al. 
2002). 
Mammalian endonucleases functioning in mRNA decay pathways under basal 
conditions remain elusive. However, there are several examples of endonucleases that 
function in mRNA decay when cells are subjected to stress or infection. For instance, 
important to the process of RNA interference (discussed in section 1.2.3) is an 
endonuclease called Argonaute 2. This enzyme is part of the RNA induced silencing 
complex and facilitates the cleavage of target mRNA during the RNAi response (Tafech 
et al. 2006). Another endonuclease functions during a response to various forms of 
cellular stress. G3BP is a phosphorylation-dependant endoribonuclease that is recruited 
to stress granules during cellular stress (Tourriere et al. 2003). G3BP has been shown to 
be a single-stranded specific endoribonuclease that can cleave the murine c-myc 
transcript between CA dinucleotides located in its 3'-UTR (Tourriere et al. 2001). It is 
thought that this protein helps to determine the fate of a various mRNAs during periods 
of cellular stress (Tourriere et al. 2003). During the unfolded protein response (UPR), 
which is characterized by a build-up of misfolded proteins in the endoplasmic reticulum, 
a Ser/Thr protein kinase/endoribonuclease called inositol-requiring enzyme 1, or IRE-1 is 
activated. This enzyme has RNase activity used to splice HAC1 pre-mRNA. HAC1 
mRNA encodes a transcription factor that activates all UPR target genes (Zhang et al. 
2005). Other endoribonucleases, including RNase L and Dicer, are involved in the 
cellular response to the introduction of foreign RNA by viral agents. RNase L is 
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CHAPTER 1 - INTRODUCTION 11 
activated by 5'-phosphorylated, 2',5'-linked oligoadenylates which are synthesized upon 
interferon-induction (Adah et al. 2001). Dicer is involved in RNA interference and will 
be discussed later in this review. A list of identified and candidate vertebrate 
endonucleases can be seen in Table 1. 
1.1.4. c-myc mRNA stability 
The c-myc gene codes for a transcription factor that associates with another 
protein called Max. The Myc-Max complex regulates the expression of many genes 
essential for cellular proliferation, differentiation and apoptosis; therefore its expression 
must be tightly regulated (Audic et al. 2004; Langa et al. 2001; Sarkar et al. 2003). One 
of the major control points of c-myc expression is through the stability of its mRNA 
(Langa et al. 2001). Improper regulation of c-myc protein levels can have harmful 
effects on an organism. For example, elevated levels of c-myc mRNA or protein can be 
observed in 66-80% of colorectal cancers (Audic et al. 2004). Also, virtually all types of 
cancers show increased levels of c-Myc protein and mRNA (Nesbit et al. 1999). In fact, 
even modest levels of abnormal regulation of c-myc can lead to neoplastic transformation 
(Mai et al. 2003). This illustrates the importance of tightly regulated expression for this 
proto-oncogene. 
The c-myc transcript contains two cis elements that help to modulate its stability 
(Figure 2). The first is an ARE located in the 3'-UTR (Audic et al. 2004; Ross. 1995; 
Langa et al. 2001). As mentioned above, the ARE has been linked to mRNA instability. 
c-myc mRNA is stabilized in both human T-cell leukemia and myeloma, and in both the 
pathological states the 3'-UTR ARE is deleted or translocated respectively (Audic et al. 
2004). However, contrary evidence has been found that shows that when the 3'-UTR is 
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removed in mice, no change in c-myc mRNA levels was observed. With these 
observations, Langa et al (2001) concluded that there must be determinants within the 
coding region that can regulate c-myc mRNA. 
The c-myc coding region determinant (CRD), located in the 3' end of the coding 
region, serves as an instability determinant. It has been shown that there is an 
endonuclease that is capable of cleaving c-myc mRNA at the C-terminal of the coding 
region in vitro (Ross. 1995; Lee et al. 1998). When full-length CRD competitor RNA 
was added to polysomes from cultured cells, endonucleolytic cleavage of c-myc mRNA 
occurred. This lead to a model suggesting the presence of a c-myc CRD binding protein 
that is capable of interacting with c-myc mRNA (Lee et al. 1998). This CRD-BP is 
believed to associate with the c-myc CRD and shield it from endonucleolytic cleavage but 
when it dissociates from the CRD, the mRNA is open to cleavage by the endonuclease 
(Ross. 1995; Lee et al. 1998; Lemm et al. 2002; Doyle et al. 1998; Bergstrom et al. 2006; 
Tafech et al. 2006). It is also thought that ribosome briefly stops translating c-myc 
mRNA upstream of the CRD. This translational pausing creates a ribosome deficient 
section at the CRD and leaves it accessible to endonucleolytic attack. The c-myc mRNA 
is cleaved and rapidly degraded unless the CRD-BP binds and protects it (Lemm et al. 
2002). Therefore, there is a race between the endonuclease and the CRD-BP for access 
to the CRD (Audic et al. 2004). The ability of the CRD-BP to protect the CRD of c-myc 
mRNA from endonucleolytic attack has been demonstrated in vitro (Sparanese et al. 
2007). 
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5'-UTR Coding Region 3'-UTR 
CRD 
Figure 2. A schematic representing the c-myc transcript. Cis elements affecting the 
stability of the mRNA include the AU rich region within the 3'-UTR and the CRD. The 
CRD is located in the 3' end of the coding region and is represented by a gray box. 
1.1.5. Evidence that mRNA degradation is a localized event in cells 
Messenger RNA decay and other post-transcriptional events such as mRNA 
surveillance, translational repression or gene silencing has been found to occur in 
localized cytoplasmic domains termed "processing bodies" or P bodies (reviewed by 
Eulalio et al. 2007). In fact, many proteins that are associated with post-translational 
events are concentrated and co-localized, along with their substrate, within P bodies; 
suggesting that these domains are the site of post-translational processes. In fact, XRN1, 
a cytoplasmic exonuclease mentioned earlier, is highly concentrated within P bodies 
where it is thought to function in degradation of mRNA (Bashkirov et al. 1997). Also, P 
bodies are important to the function of RNA interference as many of the components of 
the RNA-induced silencing complex (RISC) have been found to be concentrated within P 
bodies (Liu et al. 2005; Anderson. 2005). There are also many additional proteins 
present in P bodies that have various purposes. Proteins that function in nonsense 
mediated mRNA decay, translational repression, decapping, ARE-mediated mRNA 
decay, translational regulation and RNA polymerization have all been found to be 
components of P bodies. For an up to date list of proteins that make up P bodies see 
Eulalio et al, 2007. 
Although there is much evidence to suggest that P bodies are the site of mRNA 
decay, it is not entirely clear whether mRNA decay occurs outside of P bodies as well. 
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Certainly there are many P body components found diffusely throughout the cytoplasm. 
It has been suggested that mRNA decay is initiated in the cytoplasm but decay 
intermediates localize to P bodies where the rate of degradation is increased due to the 
high concentration of RNA catabolizing enzymes (Eulalio et al. 2007). 
It should be noted that while P bodies seem to be a site of increased mRNA 
decay, transcripts associated with them are not always destined for degradation. There is 
evidence to suggest that once an mRNA molecule has been localized to P bodies, it can 
then be returned to polysomes if it is needed again for translation (Brengures et al. 2005). 
Although this movement of mRNA between P bodies and polysomes is not fully 
understood, it appears to exist. This means that mRNAs previously tagged for 
translational repression or degradation make their way back to the ER associated 
polysomes for a possible re-activation of translation. 
1.2. Targeted knockdown of gene expression 
This thesis utilizes specific gene inactivation technologies. Therefore, the 
purpose of this section is to familiarize readers with background information necessary to 
understand the techniques used to knockdown Syntaxinl8 mRNA in cells. 
1.2.1. Strategies for specific knockdown of gene expression 
The ability to target and specifically knockout certain genes is an asset in basic 
and applied research. It partially allows for the specific or downstream effects of a 
protein to be ascertained through observation of the knockout phenotype. There are 
many strategies that may be employed in order to achieve efficient knockout. These 
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include antisense oligonucleotides, RNA interference and RNase P associated external 
guide sequences. All of these strategies work to eliminate gene expression at a post-
transcriptional level. As the transcript is pre-maturely removed from the cell, less protein 
can be transcribed from it, effectively knocking down the amount of protein that is 
expressed within the cell. This tool has proven invaluable in research and shows 
potential as a therapeutic agent as well. Only RNA interference and RNaseP-associated 
external guide sequences will be discussed, as they were used in this study. 
1.2.3. RNA Interference 
RNA interference is an evolutionary conserved mechanism through which cells 
are able to protect themselves from foreign double stranded RNA (Downward. 2004). 
The invading RNA is processed into short 21-22 nucleotide RNA fragments termed short 
interfering RNA (siRNA). Processing of the long dsRNA is done by a protein complex 
that includes the endoribonuclease Dicer (Bagasra et al. 2004; Scherer et al. 2003). The 
siRNA molecule is then integrated into the RNA-induced silencing complex (RISC) 
where it is used to recognize RNA exhibiting sequence complementarity. The 
complementary RNA is then cleaved by an endoribonuclease within RISC, called 
Argonaute 2 (Rand et al. 2004). The siRNA may then be recycled by RISC to recognize 
and facilitate the cleavage of another long RNA molecule. While the original function of 
this mechanism was to eliminate exogenous RNA from the cell, it may also be applied to 
achieve silencing of a gene. By introducing siRNA molecules with sequence 
complementarity to a target gene, it is possible to induce RISC to recognize and cleave 
endogenous mRNA, effectively silencing a particular gene (Figure 3). In fact, there are 
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many studies demonstrating the efficient knockdown of a target gene through the use of 
this technique (Hatsuzawa et al. 2006; Dorsett et al. 2004; Varambally et al. 2002). 
Ever since RNAi has been applied to mammalian cells in culture (Elbashir et al. 
2001), many in vitro studies have been conducted using siRNA in multiple cell lines. In 
one study, researchers found that the growth of the human breast cancer derived cell line, 
MCF-7 could be inhibited by siRNA targeted to the c-myc gene in vitro and in vivo 
(Wang et al. 2005). Small interfering RNA has also been used successfully to reduce the 
expression of the SNARE proteins Stxl8 (Hatsuzawa et al. 2006). While it has only 
recently been characterized (Fire et al. 1998), RNAi has proven to be an invaluable 
research tool that has been used successfully in countless studies. 
The technology of siRNA is relatively new, and as such it is still in development. 
A new trend emerging is the use of slightly longer 27mer siRNA molecules termed Dicer 
substrate siRNA. These RNA molecules are longer in order to facilitate processing by 
the Dicer complex before being inserted into RISC. This has been shown to greatly 
increase the potency of the siRNA so that much less can be used to achieve the same 
degree of silencing (Kim et al. 2005; Rose et al. 2005). In fact, it has been demonstrated 
RNA duplexes that can be processed by Dicer can be more potent by up to 100-fold (Kim 
et al. 2005). This is attributed to the fact that Dicer is part of the pre-RISC complex and 
aids in loading the siRNA onto RISC (Rose et al. 2005; Sontheimer. 2005). However, 
the increased potency is somewhat dependant on the design of the 27mer due to 
asymmetrical strand utilization of RISC, with higher potency being exhibited if the 
3'overhang is contained on the sense strand (Rose et al. 2005). However, there is still 
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much to be learnt about RNA interference and the design of effective duplexes is still a 
hit or miss process. 
1.2.4. RNase P associated external guide sequences 
RNase P associated external guide sequences (EGS) are another technology that 
can be employed to achieve targeted gene silencing. This technique works by mimicking 
pre-tRNA, which is the natural substrate for the ubiquitous endonuclease, RNase P. The 
EGS molecule is designed to contain two stem loop structures, with single strand 5' and 
3' ends. The ends are complementary to the target mRNA and when the EGS molecule is 
hybridized to its target mRNA, a structure is formed with a similar shape to pre-tRNA, 
resulting in the degradation of the mRNA by RNase P (Tafech et al. 2006; Kovrigina et 
al. 2005; Yang et al. 2006) (Figure 4). 
Silencing of genes using this technique has been observed in mammalian cells on 
several occasions. RNaseP subunits (Kovrigina et al. 2003; Zhang et al. 2004), protein 
kinase C-a (Ma et al. 2000), as well as Human Immunodeficiency Virus-1 (HIV-1) 
mRNA (Kraus et al. 2002; Barnor et al. 2004) are some examples of transcripts that have 
been successfully silenced using RNaseP-EGS technology (Tafech et al. 2006). Some 
advantages to the use of RNaseP-EGS include the ability to chemically modify the 
molecule based on experience acquired through the use of DNA antisense 
oligonucleotides, the fact that it uses a well defined degradation pathway and that the 3 ' 
end of a known G residue is cleaved within the target transcript. Disadvantages to this 
technology include its inability to target mature mRNA within the cytoplasm, mere are 
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many criteria to design a successful EGS molecule, and the fact that it can only cleave the 
3' end of a known G residue, limiting options (Tafech et al. 2006). 
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Figure 3. Strategies used in this study to facilitate the silencing of Syntaxin 18. (A) 
During RNA interference, dsRNA is cleaved by Dicer and then the antisense strand is 
incorporated into RISC, a multi proteins complex that uses the RNA to recognize and 
cleave its complementary mRNA. Conventional RNA interference introduces siRNA 
molecules that mimic the Dicer product. Dicer substrate siRNA is cleaved by Dicer 
before it is inserted into RISC and this results in a more potent gene knockdown (Kim et 
al. 2005). (B) An external guide sequence recognizes a complementary mRNA sequence 
resulting in a hybrid structure that mimic pre-tRNA. This results in a cleavage of the 
mRNA by RNase P, reducing the amount of target transcript within the cell. 
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1.3. Svntaxin 18, an ER localized protein 
Syntaxinl8 (Stxl8) has been tentatively identified as a candidate 
endoribonuclease that can cleave c-myc mRNA in vitro. The section will review the 
biochemistry of Stxl8. Stxl8 belongs to a class of proteins termed soluble N-
ethylmaleimide sensitive factor (NSF) attachment protein (SNAP) receptors (SNARE) 
that are involved in vesicle trafficking. SNARE proteins are membrane bound and serve 
to mediate fusion of two membranes. This section will also briefly review the mechanics 
of vesicle trafficking between the ER and the golgi. Also, due to the localization of 
Stxl8 to the ER membrane, it seems pertinent to review the ER-stress response pathway 
and its association with mRNA degradation processes. 
1.3.1. Vesicle Trafficking 
Transportation of proteins between the endoplasmic reticulum and the golgi 
apparatus is essential for cellular function. This is achieved through a process called 
vesicle trafficking. Proteins that are produced in polysomes on the ER must pass through 
the Golgi to reach their place of function. Also, ER resident proteins that escape to the 
Golgi must be transported back. In order to facilitate the necessary budding and fusion of 
membranes that is required for vesicle trafficking, the cell employs various proteins. 
These proteins, and the mechanism of vesicle trafficking, will be reviewed in this section. 
The movement of vesicles between the ER and the Golgi occurs in two directions. 
Ante retrograde transport is the movement of vesicles from the ER to the golgi, while the 
movement from the Golgi to the ER is termed retrograde transport. In between these two 
organelles is another compartment called the intermediate compartment, or vesicular-
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tubular clusters (VTC) (Duden. 2003) (Figure 3). Despite this complex movement of 
vesicles through multiple compartments, the protein and lipid composition of these 
membranes remains relatively steady (Duden. 2003). 
Trafficking requires many events of budding vesicles and fusing membranes. The 
fusion of two membranes is not energetically favorable and therefore requires a group of 
proteins in order to overcome this energy barrier. The ultimate fusion of membranes, 
including the homotypic fusion of two vesicles and the heterotypic fusion of a vesicle 
with its target membrane, is dependant on a well-studied class of protein. These proteins, 
termed soluble NSF-attachment protein (SNAP) receptors (SNARE), mediate the fusion 
of a vesicular membrane with a target membrane through a complementary interaction 
between a SNARE on the vesicle (v-SNARE) and a SNARE on the target membrane (t-
SNARE) (Alberts et al. 2002). The nature of this interaction, including various proteins 
associated with it, will be reviewed in the following section. 
Figure 4. A diagram of ER-goIgi trafficking. Vesicles bud from the ER and move 
towards the cis-golgi in ante-retrograde transport. They may undergo homotypic fusion 
to form vesicle tubular clusters. Vesicles bud from the Golgi and they either move 
towards the trans-golgi network or they move back towards the ER-membrane in 
retrograde transport. Syntaxin 18 is localized to the ER membrane where it functions in 
heterotypic fusion of the membrane and vesicles from the Golgi network. It has not yet 
been confirmed whether Syntaxin 18 functions in homotypic ER membrane fusion. 
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1.3.2. SNARE proteins and membrane fusion 
In order for membranes to fuse, they must overcome a substantial energy barrier. 
It was originally assumed that ATP was required for efficient membrane fusion; however, 
in actuality, this energy barrier is overcome through the formation of an extremely stable 
complex that forces two separate membranes together (Sorensen. 2005). This complex 
consists of a soluble N-ethylmaleimide sensitive factor (NSF) attachment protein (SNAP) 
and two of its receptors, one on the vesicle (v-SNARE) and one on the target membrane 
(t-SNARE). The connection between SNARE proteins and SNAP proteins was first 
indicated when the v-SNARE synaptobrevin 2, and the t-SNARE syntaxin 1 were co-
isolated with SNAP-25 through affinity purification (Sollner et al. 1993). Once the link 
between SNARE and SNAP proteins was established, it was possible to develop an 
acceptable model for membrane fusion. 
Throughout the secretory pathway, vesicles must continuously bud from and fuse 
with other membranes. This is mediate through various proteins including NSF, SNAP, 
and SNARE proteins. As the two membranes to be fused approach each other, there is a 
formation of an extremely stable complex between the t-SNARE, SNAP protein and the 
v-SNARE, each contributing one, two and one a-helices respectively (Teng et al. 2001). 
This reaction is dependant on the Ca2+ signal and forces the two membranes into close 
proximity. The result is that the membranes fuse, becoming one membrane and releasing 
the contents of the vesicle into the target organelle (Teng et al. 2001; Sorensen. 2005; 
Alberts et al. 2002). NSF, an ATPase, then catalyses the dissociation of the two SNARE 
proteins and the SNAP so that they can be recycled for another round of membrane 
fusion (Alberts et al. 2002; Bock et al. 2001). 
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Since the discovery of syntaxin 1 and synaptobrevin 2, there have been many 
members of the SNARE family that have been characterized. To date, in mammals, their 
have been 15 different t-SNAREs, or syntaxins, characterized; including several 
alternatively spliced isoforms of at least four. This amounts to a current total of twenty-
four known syntaxins (Teng et al. 2001). Some of these t-SNAREs are only found in 
specific tissue types. For example, Syntaxin 1A functions in neuronal exocytosis and 
regulated secretion and is therefore only expressed in neuronal or secretory cells (Teng et 
al. 2001; Neren et al. 2000). Other syntaxins are expressed ubiquitously but are localized 
to certain membranes within the cell. An example of this is Syntaxin 8, which is 
localized to the endosome and functions in the recycling of surface proteins (Teng et al. 
2001). This study will focus on a t-SNARE protein, Syntaxin 18, which is localized to 
the ER and functions in ER-Golgi trafficking. Current knowledge about Syntaxin 18 will 
be reviewed in detail in the following section. 
1.3.3. Structure and function of Syntaxin 18 
Syntaxin 18 (Stxl8) is a SNARE protein localized to the ER membrane, and it 
primarily functions to mediate docking between trafficking vesicles and the ER 
membrane in ER-Golgi transport (Hatsuzawa et al. 2000; Bossis et al. 2005). Six 18 is 
anchored to the ER membrane at its carboxy terminus. The majority of the polypeptide 
sequences faces out towards the cytoplasm and a membrane proximal coiled-coil domain, 
approximately 60 residues long, acts as the SNARE domain (Teng et al. 2001) (Figure 4). 
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A B 
Figure 5. The structure of Syntaxinl8. Structure A, B and C show the structure of 
Syntaxinl8 as predicted by the Roberta Full-Chain Protein Structure Prediction Server 
(Kim et al. 2004). A) A ribbon representation of the protein when observed along the 
ER-membrane. B) A ribbon representation of the protein as observer when looking 
towards the ER membrane. C) A space filling model of the Stxl8 protein. D) A 
schematic representation of a SNARE protein (Teng et al. 2001). 
Stxl8 helps to mediate docking between the ER-membrane and vesicles 
originating from the Golgi. This is achieved through the interaction of the SNARE 
domain on Stxl8 with the SNARE domain on the incoming v-SNARE protein such as 
rSec22b (Hatsuzawa et al. 2000). The SNAP protein also contributes two more a-
helices, resulting in a four-helical bundle structure that effectively creates a bridge 
between the vesicle and the ER-membrane (Teng et al. 2001). Initially, Stxl8 is loosely 
associated with the v-SNARE and SNAP a-helices in what in known as the trans-
conformation. Upon the arrival of a Ca2+ signal, the syntaxin becomes fully associated 
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with the SNAP protein and its counterpart on the vesicle. This results in the formation of 
the cis-complex and a zipping up effect that begins at the amino-terminus of the complex 
and moves towards the carboxy-terminus. The result is that the two membranes are 
forced into close proximity resulting in final membrane fusion (Teng et al. 2001). 
Studies have shown that the over-expression of Stxl8 cause aggregation of the ER 
membrane and inhibits the flow of traffic between the ER and the Golgi (Hatsuzawa et al. 
2000). Also, the null phenotype of its homologue, Ufelp, in yeast is lethal (Teng et al. 
2001). However, there is no evidence to date that the knockout of Stxl8 in mammalian 
cells is detrimental. One study used siRNA to effectively knockdown Stxl8 and a 
reduced efficiency in ER-mediated phagocytosis was observed. The same study showed 
that a stable over-expression of Stxl8 increased the efficiency of ER-mediated 
phagocytosis, implicating the t-SNARE as an important player in fusion between the ER-
membrane and the plasma or phagosomal membranes (Hatsuzawa et al. 2006). While 
both Stxl8 and Ufelp have each been implicated in retrograde transport between the 
golgi and the ER, only Ufelp has been shown to function in homotypic fusion of the ER 
membrane (Arasaki et al. 2006; Lewis et al. 1996; Patel et al. 1998). It is currently 
unknown whether Stxl8 plays a role in homotypic ER fusion although it has been 
suggested (Hatsuzawa et al. 2000). 
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Figure 6. A diagram representing the fusion of a vesicle from the golgi with the ER 
membrane. The t-SNARE Syntaxin 18 (red), the v-SNARE Sec22b (green), and <x-
SNAP (blue) contribute one, one and two a helices respectively. This interaction is 
highly energetically favorable and forces the two membranes into close proximity, 
ultimately facilitating fusion. After fusion, NSF catalyzes the dissociation of the protein 
complex so that they may be used in another round of fusion (Alberts et al. 2002). 
Syntaxin 18 has been shown to associate with a wide array of proteins in the 
formation of a large complex. These proteins include SNARE proteins p31, BNIP1, and 
Sec22b (Arasaki et al. 2006) as well as ZW10 and RINT1, two peripheral membrane 
proteins (Arasaki et al. 2006; Hirose et al. 2004; Nakajima et al. 2004) and NSF and cc-
SNAP (Teng et al. 2001). BNIP1 plays in important role in apoptosis (Nakajima et al. 
2004). ZW10 is a spindle checkpoint protein, and as such plays an important role in the 
proper segregation of sister chromatids during cellular division (Hirose et al. 2004); 
while RINT1 has been shown to regulate the incorporation of ZW10 into the Stxl8 
complex (Arasaki et al. 2006). Given the diverse roles of the aforementioned proteins, 
one could expect Stxl8 to play a role in multiple cellular processes; however, current 
studies have only demonstrated that ZW10 is important to efficient ER-Golgi trafficking 
and BNIP1 may help to mediate crosstalk between membrane fusion and apoptosis 
(Hirose et al. 2004; Nakajima et al. 2004). So far, dual functionality of proteins 
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associated with Stxl8 has been supported, but the role of Stxl8 itself is limited to ER-
Golgi trafficking and ER-mediated phagocytosis (Hatsuzawa et al. 2006). In fact, our lab 
has demonstrated possible endonuclease activity of Syntaxin 18 in vitro; raising the 
possibility that the t-SNARE protein may function in mRNA decay in vivo. 
1.3.4. ER membrane aggregation and the ER stress response 
As mentioned earlier, the overexpression of Syntaxin 18 leads to aggregation of 
the ER (Hatsuzawa et al. 2000). Conditions that reduce the ability of the ER to properly 
fold proteins leads to an ER stress condition referred to as the ER stress response or 
unfolded protein response (UPR) (Szegezdi et al. 2006). In order to interpret some of the 
results of this study, it would be helpful to understand the ER stress response, since it is 
possible that this state may occur upon differentiating in Stxl8 expression. 
The UPR is a response that allows the cell to either restore the ER to normal 
function or, if it cannot be restored, induce apoptosis. The UPR functions in three 
distinct steps. The first is a general halting of translation through the PERK pathway by 
phosphorylation and deactivation of the translation factor eIF2a (Zhao et al. 2006). 
Secondly, genes involved in protein folding and ER-associated degradation are 
upregulated through the ATF6, IRE1 pathway. ATF6 acts as a transcription factor while 
IRE1 endonucleolytically cleaves and alternatively splices the mRNA of the Xbpl 
transcription factor, resulting in the production of full length XBP1 (Zhao et al. 2006; 
Szegezdi et al. 2006; Zhang et al. 2005). If the above strategies cannot restore normal 
ER function, then the third step is to enter apoptosis and remove the cell from the 
population (Szegezdi et al. 2006). There is also evidence to suggest that IRE1 can act on 
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multiple ER localized transcripts, including SPARC mRNA (Hollien et al. 2006). 
SPARC is a "matricellular glycoprotein that is capable of inhibiting the growth of several 
different types of cancer (Chelenski et al. 2007)." 
During the UPR, many genes are indirectly affected. DNA microarray analysis 
has shown that many transcripts are up-regulated, including genes that are associated 
with vesicle trafficking and transport (Travers et al. 2000). This includes the protein 
BOS1, which functions as a SNARE protein in ER-Golgi transport in yeast (Travers et al. 
2000; Perlati et al. 2002). Also, the UPR results in an inhibition of the cell cycle through 
inhibition of cyclin Dl through the PERK pathway (Zhao et al. 2006). Other genes that 
are affected by the UPR include genes associated with protein modification and 
glycosylation, lipid metabolism, vacuolar protein sorting and cell wall biogenesis 
(Travers et al, 2000). This demonstrates that any condition that may elicit the UPR will 
have a global effect of the cell, resulting in a global change in gene expression and 
protein levels. 
1.3.5. Syntaxinl8 as an endoribonuclease in vitro 
There are two enzymes that have been identified to cleave c-myc mRNA within 
the coding region in vitro. The first is the 39kDa polysome-associated c-myc CRD 
endonuclease (Lee et al. 1998). The other enzyme is a 35kDa protein that was 
discovered during efforts to purify the 39kDa protein (Bergstrom et al. 2006). The 
purified endoribonucleolitic activity does not appear to be tissue specific and it 
preferentially cleaves UA, UG and CA dinucleotides (Bergstrom et al. 2004). It does not 
appear to be Mg2+ dependant and is resistant to RNase inhibition (Bergstrom et al. 2006). 
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The 35kDa endonuclease was tentatively identified as Syntaxin 18 in the first attempt of 
MALDI-mass spectrophotometry analysis. Using the SVMProt: Protein Functional 
Family Prediction software program, human Stxl8 was predicted to belong to an mRNA-
binding family of proteins. (Cai et al. 2005). The recombinant form of human Stxl8 has 
been generated in the Lee laboratory and showed to possess endonuclease activity. 
Stxl8, and more specifically, its role in affecting stability of c-myc mRNA as well as cell 
survivability, is the focus of this MSc thesis. 
1.4 Research Goals 
As of now, the endonuclease that cleaves the c-myc transcript within the CRD 
remains to be definitively identified. In spite of this, our lab has tentatively discovered 
that recombinant Syntaxinl8 possesses endoribonuclease activity in vitro when 
challenged with c-myc CRD RNA (unpublished results). However, it is unknown 
whether the same is true in cells. The focus of the MSc thesis was to determine whether 
Syntaxinl8 has the ability to affect the levels of c-myc transcript, lending evidence to the 
possibility that it may have a biological role as an endoribonuclease in vivo. Should 
Stxl8 acts as an endonuclease on c-myc mRNA, then modulating its expression might 
either stabilize of destabilize the transcript. For example, if Stxl8 can cleave c-myc 
mRNA, then reducing its expression may stabilize the transcript. Also, increasing Stxl8 
expression may have the reverse effect on the mRNA. 
Aim I of this investigation was to determine the expression of Stxl8 among 
various immortalized cell lines. Subsequent aims of this investigation would use tumor 
derived cell lines as an experimental model; therefore, it was necessary to find suitable 
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candidate cell lines. The original goal was to find a cell line expressing high amounts of 
Six 18 and another expression little of none of the protein in the hope of being able to 
down-regulate and up-regulate its expression respectively. In addition, expression in 
cancerous tissue was compared to normal tissue using Western analysis. 
Aim II of this research thesis was to up-regulate the expression of Stxl8 and 
examine the effect of this on cell survivability and c-myc mRNA expression. MTT 
assays were used to assess the effect of up-regulating Stxl8 on cell survival and 
proliferation. Ribonuclease protection assays were used to investigate c-myc mRNA 
expression. 
Aim III of this investigation was to down-regulate the levels of Stxl8 and 
determine its effect on cell survivability and c-myc mRNA levels and half-life. Both 
RNA interference and RNaseP-associated external guide sequences were assessed for 
their ability to achieve knockdown of Stxl8. 
It was anticipated that the above three aims will help in answering the following 
questions: (i) What is the expression profile of Stxl8 among different tissue types? (ii) 
Does modulating Stxl8 expression levels alter the survivability or proliferation rate of 
live cells? (iii) Does modulating Stxl8 protein levels affect the stability of the c-myc 
transcript? This study should permit us to test the hypothesis that Syntaxinl8 can 
influence c-myc mRNA expression in cells via its role as an endoribonuclease. 
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Chapter 2 
Expression of Syntaxinl8 and Optimizations of Transfection 
Efficiency 
Aim I of this thesis was to determine the expression of Syntaxin 18 in multiple 
cell lines. In addition, cancerous and normal breast tissue samples were compared for 
Syntaxin 18 expression. 
2.1. Materials and Methods 
2.1.1. Cell Culture Methods 
Human breast cancer cell lines MCF-7, MCF-7Adrand LCC6 and leukemia derived 
cell lines K562, KG l a and KG la200 were each cultured in DMEM (Gibco, Grand Island 
NY) supplemented with 10% Fetal Bovine Serum (Hyclone, South Logan, UT) and 
lOOug/ml Penicillin/Streptomycin (Hyclone, South Logan UT). Ovarian cancer derived 
cell lines HeLa and SKOV3, prostate cancer derived cell line Du-145, and liver cancer 
derived cell lines HepG2 and SK-Hep-1 were cultured in MEM (Gibco, Grand Island 
NY) supplemented with 10% Fetal Bovine Serum and 100(j,g/ml Penicillin/Streptomycin. 
The cervical cancer derived cell line CEM and the prostate cancer derived cells LNCaP 
were cultured in RPMI-1640 (Gibco, Grand Island, NY) supplemented with 10% Fetal 
Bovine Serum and 100p.g/ml Penicillin/Streptomycin. All cell lines were cultured at 
37°C in a 5% C0 2 incubator. Cells were passaged every 2-3 days or once approximately 
90% confluency was reached. During passaging, cells were diluted 10 times into fresh 
culture medium. 
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2.1.2. Cell Lysis and Protein Quantification of Cell Lines 
Before lysis, cells were washed with PBS pH 7.2 (Gibco, Grand Island NY). 
Adherent cells were scrapped loose and resuspended in lysis buffer (50mM Tris, pH8; 
150mM NaCl; 0.1% SDS; 0.5% Na deoxycholate; 1% NP-40; 0.02% sodium azide). 
Cells in suspension were pelleted and resuspended in lysis buffer. Lysate was incubated 
on ice for 30 minutes, vortexing every 5 minutes. Lysate was centrifuged for 15 minutes 
at 13,200rpm and the supernatant was removed and 2ul was used in protein 
quantification. The rest was stored at -20°C until western analysis. Protein quantification 
was using a standard Bradford Assay (BioRad, Hercules CA). In short, 2ul of cell lysate 
was mixed with 200ul Bradford Dye and 798ul ddH20. Samples were incubated for 15 
minutes and the absorbance at 595nm was read on a Thermo Multiscan Ascent 
microplate reader (Thermo Fisher Scientific, Waltham MA). Standardized bovine serum 
albumin (New England Biolabs, Ipswich MA) protein, lOmg/mL was used to generate a 
standard curve (0-30 |ag/ml range). 
2.1.3. Cell Lysis and Protein Quantification of Tissue Samples 
Frozen tissue samples (breast cancer tissues 8034B and 9018B, and normal breast 
tissue N37C) were acquired from the Manitoba Breast Tumor Bank (MBTB). Frozen 
tissue samples were resuspended in to 400ul of lysis buffer B (lOOmM NH2PO4; lOmM 
Tris-Cl; 8M Urea). Samples were then subjected to 3 cycles of freeze-thaw (-80°C for 
lOmins followed by 5mins at 42°C) with vigorous vortexing in between each cycle. 
Next, the samples were centrifuged (13200rpm; 15 minutes) and the supernatant was 
removed for analysis. Protein levels were quantified in the same manner as described in 
section 2.1.2. 
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2.1.4. Acetone Precipitation of Proteins 
If the cell lysates were too dilute to run the appropriate amount protein for 
western analysis, they were subjected to acetone precipitation. To do this, total protein 
was mixed with 4 volumes of 100% acetone and incubated at -20°C for at least 1 hour. 
Precipitate was centrifuged (13200rpm, 4°C, 10 minutes) and rinsed once with 80% 
acetone. Pellets were air dried and resuspended into ddFkO for western analysis. 
2.1.5. Western Analysis of Cell Extracts 
Cell lysate of tissue extract was run on a 12% SDS-PAGE. Samples were run at 
240V for approximately 45 minutes. Protein was transferred to a nitrocellulose 
membrane at 110V for 50 minutes. Membrane was blocked with a 5% milk solution (5% 
skim milk powder; 0.8% NaCl (w/v); 25mM Tris; 2.5mM KC1 ) for 2 hours at room 
temperature. Next, the membrane was incubated with 1° antibody diluted 1:1500 in ST 
buffer (0.8% NaCl (w/v); 25mM Tris; 2.5mM KC1; 0.1% Tween 20) for 2 hours followed 
by incubation with 2° antibody (1:2500) for 1 hour. Rabbit generated polyclonal anti-
syntaxin antibody was custom using a Stxl8 oligopeptide as an antigen (animal#9950, 
weeklO, Invitrogen). Monoclonal anti-p-actin antibody was from Sigma. Secondary 
antibodies anti-mouse IgG and anti-rabbit IgG were from Promega (Wyoming, MI). 
Incubations were carried out at room temperature with slight agitation. Membranes were 
then incubated with SuperSignal West Pico Chemiluminescent substrate (Pierce, 
Rockford IL) as per manufacturer's protocol and visualized using a Chemlmager (Alpha 
Innotech, San Leandro CA). 
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2.1.6. Stripping of Western Blots 
Western blots to be re-probed were stripped by incubating the blots with stripping 
buffer (Tris 62mM; 2.0% SDS (w/v); 0.7% p-mercaptoethanol (v/v)) heated to 50°C for 
30 minutes. After the initial 15 minutes, the stripping buffer was poured off and replaced 
with fresh buffer for an additional 15 minutes. Membrane was washed in ST buffer, re-
blocked and probed with alternate antibodies as described above. 
2.2. Results and Discussion 
2.2.1. Screening Cell Lines and Breast Tissue Samples for Syntaxinl8 Expression 
It is unknown whether Syntaxin 18 demonstrates ubiquitous tissue distribution 
(Teng et al, 2001). The initial goal of Aim I was to identify cell line(s) that expressed 
abundant Syntaxin 18 and cell line(s) that exhibited little expression of the protein. In 
order to do this, 12 different cell lines derived from 6 different tissues were propagated, 
lysed and examined through western analysis. These cell lines included breast cancer 
derived cell lines MCF-7, MCF-7Adr and LCC6; bone marrow derived cell lines K562 and 
KGla and KGla200; ovarian derived cell line SKOV3; cervical cancer derived cell line 
HeLa; liver derived cell lines HepG2 and SK-Hep-1; prostate derived cell lines Du-145 
and LNCaP; and peripheral blood derived cell line CEM. Each of these cell lines were 
derived from tumors in the tissue from which they originate. The expression of Syntaxin 
18 within these cell lines was assessed using a polyclonal antibody raised against a 
peptide sequence specific to the Syntaxinl8 protein. This antibody has previously been 
demonstrated to detect recombinant Stxl8 by another graduate student, demonstrating its 
affinity and specificity to the protein of interest. The results of the cell line screening can 
be observed in Figure 7. 
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Figure 7 The expression of Syntaxin 18 in various cell lines. 40ug of total protein 
was run on a 12% SDS-PAGE and transferred to a nitrocellulose membrane. The 
membranes were probed with polyclonal a-Stxl8 1° antibody and a-Rabbit IgG 2° 
antibody and visualized. Membranes were then stripped and re-probed with monoclonal 
a-p-actin 1° antibody and a-Mouse IgG 2° antibody. 
From Figure 7 it can be observed that all cell lines examined demonstrated 
Syntaxinl8 expression. Interestingly, there were also multiple bands of different 
molecular weights observed. In fact, it has been observed that SNARE proteins will form 
SDS-resistant tertiary structures and when run on SDS-PAGE and analyzed by western 
blot, multiple bands may be observed (Poirier et al. 1998; Otto et al. 1997; Hayashi et al. 
1994). The tertiary SNARE complex formed between syntaxinl, SNAP-25 and 
Synaptobrevin during neurotransmitter release is SDS-resistant and when probed with 
anti-syntaxin la antibody, at least 2 bands are observed (Poirier et al, 1998). Similarly, 
during endosomal trafficking, syntaxin 7, syntaxin 8, endobrevin and vtilb form a 
SNARE complex that is SDS-resistant, although the resistance is less pronounced than its 
synaptic counter part (Atonin et al. 2000). It is possible that the multiple bands observed 
in Figure 7 may be due to the formation of extremely stable complexes between Syntaxin 
18 and its associated proteins such as Sec22b and oc-SNAP. The molecular size of 
Syntaxinl8 is 39kDa (Hatsuzawa et al. 2000) while that of Sec22b is 24kDa (Zhang et al. 
1999) and a-SNAP is 35kDa (Wimmer et al. 2001). It seems likely that the lower band 
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of about 35-39kDa seen in each lane is Syntaxin 18 itself while the band that is observed 
just above 50 kDa may be Syntaxinl8 complexed with Sec22b. Samples showing a 
fourth band at ~55kDa, including MCF-7adr, LNCAP, K562, KG la, KG la200 and SK-
Hep-1 may be showing Syntaxinl8 bound to oc-SNAP. Multiple bands could possibly be 
due to Stxl8 forming a complex with one or more of its associated proteins. 
Other possible reasons for seeing multiple bands include possible alternatively 
spliced isoforms of the protein that contain recognizable epitopes for the antibody, post-
translational modifications of Stxl8, or non-specific binding of the polyclonal antibody 
due to unrelated proteins containing recognizable epitopes. It is unknown whether 
syntaxinl8 is modified post-translationally. A group investigating a syntaxin homologue 
in plants, AtPEP12p, found multiple bands when they probed their western with a-
AtPEP12p (Conceicao et al. 1997). Upon addition of several protease inhibitors to their 
extraction procedure, they continued to observe two bands. Through this they concluded 
that the multiple bands were not a result of protein degradation. Also, when they 
overexpressed AtPEP12p through introduction of its cDNA, an increase in the level of 
both bands were observed, indicating that the multiple bands were likely not a product of 
alternative splicing. Therefore, they concluded that the most likely source of the two 
bands was a post-translational modification of the protein. However, they could not 
exclude the possibility that the antibody was cross-reacting with an unidentified protein 
(Conceicao et al. 1997). 
At least three bands are seen in all cell lines with one showing as many as five 
bands (SK-Hep-1). With so many bands present, it is likely that we may be observing a 
combination of the reasons mentioned above. If Stxl8 it associated with another SNARE 
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of SNAP proteins, then various post-translational modifications of those proteins would 
appear to change the size of Stxl8. Also, since the anti-syntaxin antibody was raised 
against a polypeptide (N-terminal 14aa's of Stxl8), it possible that we are observing 
cross reactivity of the antibody with other non-syntaxin proteins. This is a polyclonal 
antibody and therefore the pool of antibodies will recognize multiple epitopes. Cross 
reactivity is highly possible, especially considering that the antibody used in this study 
was not affinity purified. A summary of the cell lines and the bands associated with them 
can be seen in Table 2. 
Table 2. The Cell Lines That Were Screened in This Study as Well as the 
Approximate Size of all Bands Observed. 
Cell Line Derived From Syntaxin 18 Number of Bands Approximate sizes 
Tissue Expression? Observed bands (kPa) 
MCF-7 
MCF-7adr 
LCC6 
K562 
KG1a 
KG1a200 
CEM 
HeLa 
SKOV3 
Du-145 
LNCaP 
HepG2 
SK-Hep-1 
Breast 
Breast 
Breast 
Bone Marrow 
Bone Morrow 
Bone Marrow 
Peripheral Blood 
Cervix 
Ovaries 
Prostate 
Prostate 
Liver 
Liver 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
4 
4 
3 
4 
4 
4 
3 
3 
3 
4 
4 
4 
5 
35,40,45,55 
35,40,55,65 
35,40,55 
35,40,55,65 
35,40,55,65 
35,40,55,65 
35,40,55 
35,40,55 
35,40,55 
35,40,45,55 
35,40,55,65 
35,40,45,55 
35,40,45,55,65 
Due to its molecular weight, and the known molecular weight of syntaxinl8, is 
likely that the band of ~35-39kDa represents a monomer of the protein of interest. Based 
on that assumption, then all cell lines express syntaxin 18 and relatively equal amounts. 
When the bottom band is compared to the p-actin blot, the ratio between samples appears 
to be equal. This indicates that in all cell lines tested, we see a ubiquitous distribution of 
Stxl8. The initial goal of this experiment was to discover a cell line expressing low 
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amounts of the protein for up-regulation experiments and one expressing high amounts 
for down-regulation experiments. As this does not seem to be possible based of these 
results, two cell lines were chosen for subsequent experiments. Breast tumor derived 
MCF-7 and ovarian tumor derived SKOV3 cell lines were used as an experimental model 
for further experiments. These cell lines were chosen due to there fast doubling time 
(37hrs for MCF-7; 32hrs for SKOV3) (Smith et al. 1999; Jiang et al. 2005). Also, these 
cell lines have been used in many studies and there was a large body of literature from 
which to extract information. 
During the screening of cell lines, it was also of interest to compare the 
expression of Stxl8 between normal and tumorigenic tissues. Breast tissue samples 
obtained from the Manitoba Breast Tumor Bank (MBTB), were screened in the same 
manner as the cell lines. Two samples were of tumorigenic (8034B and 9018B) breast 
tissue while one was a normal sample (N37C). The results of the screening can be seen 
in Figure 8. 
From Figure 8, it appears that a similar banding pattern is observed as the breast 
tissue derived cell line MCF-7. Three bands in total are observed in the tumorigenic 
samples (8034B and 9018B at -35, 55 and 65kDa); however, only two bands, the 
~35kDa band and the ~65KDa band, seem to be present in the normal sample (N37C). 
Also, the overall expression appears to be higher in the higher ~55kDa band in the two 
cancerous samples relative to the normal sample. Similarly, the ~35kDa which likely 
represents Stxl8 exhibits lower expression within the normal tissue when compared to 
the tumorigenic tissue. 
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Figure 8. A western analysis of normal breast tissue and breast cancer tissue 
samples showing differential Syntaxinl8 expression. 8034B and 9018B are 
tumorigenic while N37C was from a normal patient. Samples were generously donated 
by Dr. Sandy Troup, MBTB. 
One characteristic of tumors is a deregulation of gene expression (Audic et al. 
2004). Therefore, it seems reasonable that the differential gene expression that is 
observed is due to the genotypic profile of the cancerous tissues being different from that 
of the healthy tissue. It is interesting that all of the bands show lower expression in the 
normal tissue. As stated above, SNARE proteins for stable complexes with each other 
and these complexes are SDS-resistant. It may be possible that syntaxinl8 and other 
proteins that it complexes with are present at increased levels in cancer, resulting in the 
higher intensity bands associated with the cancerous samples in this screening. 
Alternatively, if Stxl8 undergoes certain post-translational modifications in cancer that 
are not normally present, then you would expect to see a different set of bands between 
the two phenotypes. In fact, there are proteins that exhibit post-translational modification 
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in tumors whereas they do not in normal tissue (Krueger et al. 2006). This scenario 
might explain why we see a lack of band at ~55kDa in the normal tissue. The 
modification required to produce that specific band might not be accomplished in the 
normal cells. The third possible explanation for the different banding seen between the 
normal sample and the tumorigenic sample is that there is a differential expression of 
unknown proteins with which the antibody is cross-reacting. However, as will be seen 
later in this thesis, knocking out Syntaxinl8 results in a lowered expression of all bands, 
therefore this explanation is unlikely, as it is unlikely that EGS targeting Six 18 will also 
knockout specific proteins that cross-react with the antibody. 
It appears that Stxl8 expression may vary between normal and carcinogenic 
breast tissue. In order to confirm this, Dr. Kuo-Hsing Kuo from the University of 
Northern British Columbia did immunohistochemistry staining against Stxl8 in normal 
and cancerous breast tissue. The results of the experiment were generously provided by 
Dr. Kuo and can be observed in Figure 9. 
From Figure 9 it appears that in the samples of invasive breast carcinoma (B and 
C), a more intense staining is observed compared to the normal human breast tissue. This 
result seems to support what was observed in Figure 8 and implies that Stxl8 has an 
increased level of expression within breast tumors. 
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Figure 9. Expression of Syntaxinl8 in normal human breast tissues and breast 
carcinoma. (A) The expression of Syntaxin 18 is weak in normal human breast tissue 
and mainly observed in ductal region. This image is representative of three cases. (B) and 
(C) Syntaxin 18 is highly expressed in invasive breast carcinoma in two representative 
cases of breast carcinoma, compared to the expression level in the normal human breast 
tissue. These two images are representative of 7 cases. Image (C) is from sample 
8034B. This data was provided by Dr. Kuo-Hsing Kuo from the University of Northern 
British Columbia. 
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In the western analysis (Figure 8) we observe multiple bands resulting from 
probing with the anti-Stxl8 antibody. We must therefore assume that those same 
proteins or protein complexes were detected in this experiment. It is currently unknown 
whether the multiple bands observed are a result of post-translational modifications, 
complex formations or non-specific antibody cross-reactions; in any case, there does 
appear to be a greater amount of antigen present in the cancerous tissue, compared to the 
normal tissue. 
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Chapter 3 
The Effects of Up-Regulation of Syntaxinl8 on Cell Survival 
and c-myc Gene Expression 
This chapter aimed at investigating the effects of up-regulating syntaxinl8 on cell 
survival and c-myc gene expression. This chapter describes the methods used in 
achieving this aim, as well as the results obtained. The relevant results and their 
significance in relation to the research question will be discussed. 
3.1. Materials and Methods 
3.1.1. Preparation of Competent Escherichia coli DH5a cells 
E. coli DH5a cells were grown in 50mL LB broth (Invitrogen, Toronto ONT) at 
37°C with agitation until OD600 was between 0.4 and 0.5. The cells were pelleted by 
centrifugation at 3000 rpm, 4°C. The pellet was resuspended in 25mL chilled 50mM 
CaCl2 (Sigma, St.Louis MO) and incubated on ice for 20 minutes. Cells were centrifuged 
as before and resuspended into 5mL 50mM CaCl2. Competent cell suspension was stored 
at 4°C for no more than 2 weeks. 
3.1.2. Heat-Shock Transformation of E. coli DH5a Cells 
50ul of competent cells were mixed with 50-100ng of plasmid DNA into a 1.5mL 
eppendorf tube. Mixture was chilled on ice for 20 minutes and the placed into a 42°C 
water bath for 2 minutes followed by an additional 2 minutes on ice. lnxL of LB broth 
was added to the transformed cells and they were incubated at 37°C with agitation for 1 
hour. 20(0.1 of the transformed cells were streaked onto LB agar plate (Invitrogen) with 
appropriate selective antibiotics and placed at 37°C overnight. The following day, a 
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single colony was chosen to produce a starter culture for plasmid purification (below). 
Agar plates were stored for up to 1 week at 4°C. 
3.1.3. Large Scale Purification of Plasmid DNA 
A single transformed colony was added to 2mL of LB broth with antibiotic 
selection. The starter culture was incubated at 37°C with agitation overnight. The 
following day, lOul was inoculated into 250mL of selective LB broth and incubated 
overnight at 37°C with agitation. The next day, the cells were pelleted by centrifugation 
(5000rpm, 4°C, 15 minutes). The pellet was resuspended into 5mL of Solution A (50mM 
Glucose; 25mM Tris-HCl, pH8; lOmM EDTA). 250ml of lysozyme (50mg/ml) was 
added and the lysate was incubated at room temperature for 5 minutes and then chilled on 
ice. lOmL of Solution B (0.2N NaOH; 1% SDS) was added to the lysate and incubated 
on ice for 5 minutes. Next, 7.5mL of Solution C (3M KOAc; 11.5% (v/v) Glacial acetic 
acid) was added and the lysate was incubated for 5 minutes on ice. Cellular debris was 
pelleted by centrifugation (lOOOOrpm, 4°C, 10 minutes) and the supernatant was extracted 
once by standard phenol/chloroform extraction (outlined below) and then precipitated 
with equal volumes isopropanol. Precipitate was pelleted by centrifugation (lOOOOrpm, 
4°C, 20 minutes) and the supernatant was decanted. The pellet was resuspended into 
250ul TE buffer (lOmM Tris; ImM EDTA; pH 7.2) and incubated at 37°C with RNase A 
at a final concentration of 10|ag/mL for 30 minutes. 200ul of PEG buffer (20% PEG; 2M 
NaCl) was added and the sample was incubated at -20°C for at least 30 minutes. 
Precipitate was pelleted by centrifugation and rinsed with 70% ethanol. The DNA was 
vacuum dried and resuspended into 400p.L ddH20. The DNA was quantified on a 
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spectrophotometer and diluted to lmg/ml. Purified plasmids were aliquoted in lOOul 
aliquots and stored at -80°C until use. 
3.1.4. Standard Phenol/Chloroform Extraction 
One half volume of phenol saturated in 0.1M citrate buffer, pH 4.2 (Sigma, St. 
Louise MO) and Vz volume chloroform: isoamyl alcohol (49:1) (Sigma, St Louis MO) 
was added to the sample. Samples were mixed thoroughly and centrifuged (12000rpm, 5 
minutes). The top layer was extracted and one volume of chloroform: isoamyl alcohol 
(49:1) was added. Sample was mixed thoroughly and centrifuged as before. The top 
layer was extracted and precipitated using isopropanol or standard ethanol precipitation 
procedure. 
3.1.5. Plasmids 
A vector (pCMV6-XL5) containing Homo sapiens syntaxin 18 cDNA (Clone #: 
BC1629_B02) (pCMV-XL5-Stxl8) was obtained from Origene Technologies Inc 
(Rockville MD). Empty vector (pCMV-XL5) and a vector containing (pCMV-XL5-
Stxl8ATM) a transmembrane deletion within the syntaxinl8 cDNA was generated by Dr. 
Chow Lee. In short, to generate pCMV-XL5, the plasmid pCMV-XL5-Stxl8 was 
digested with EcoRI and Xbal, to remove Stxl8 cDNA. The vector fragment was 
separated on a 1% agarose gel and gel purified using a Qiagen Gel Purification Kit as per 
manufacturers protocol (Qiagen, Mississauga ONT). Sticky ends were filled in using T4 
DNA Polymerase. Plasmid was closed using DNA ligase (NE Biolabs). To generate 
pCMV-XL5-Stx!8ATM, pCMV-XL5-Stx!8 was digested with BamHI and Smal. Sticky 
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ends were filled in using T4 DNA Polymerase. Plasmid was closed using DNA ligase 
(NE Biolabs). The pCMV6-XL5 vector map can be seen in Figure 10. 
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Figure 10. Mammalian expression vectors used in the expression of Syntaxinl8. (A) 
A pCMV6-XL5 vector containing human Syntaxinl8 cDNA was purchased from 
Origene Technologies. Empty vector (pCMV-XL5) and vector containing the cDNA for 
transmembrane deleted Syntaxinl8 (pCMV-XL5-Stxl8ATM) was generated by digesting 
the clone with EcoRI and Xbal or BamHI and Smal respectively. (B) pCMV-Tag 2 was 
purchased from Stratagene. cDNA for syntaxinl8 was cloned into Pstl/Xhol sites of the 
vector. 
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To tag the expressed protein for easy detection, a FLAG-Tagged expression 
vector was used. pCMV-Tag2 vector was obtained from Stratagene (La Jolla CA). The 
cDNA for human Syntaxinl8 was amplified by PCR (XhoIFTX18 5'-
CGACCTCGAGATGGCGGTGGACATCACG-3'; PstIRTX18 5'-CTCCTGCAGCCTG 
GCTAGCTGTCGTAC-3') and subsequently cloned into the plasmid, in frame with the 
Tag sequence, using Pstl/Xhol sites within the MCS of the vector to generate the plasmid 
pCMV-Tag2a-Stxl8. 
Table 3. Plasmid Expression Vectors That Were Used in This Study. 
Plasmid Name Effector Gene 
or Molecule 
- E x p e r i m e n t o e t Antibiotic resistance 
pcDNA3.1/His/LacZ 
pCMV-Tag2 
pCMV-Tag2-Stxl8 
pCMV-XL5 
pCMV-XL5-Stxl8 
pCMV-XL5-Stxl8ATM 
pmU6-EGSl 
pmU6-EGS3 
pmU6-EGS4 
LacZ gene 
None (-ive control) 
Flag Tagged Syntaxin 18 
None (-ive control) 
Syntaxin 18 
Syntaxin 18 with a 
transmembrane deletion 
External guide sequence 
External guide sequence 
External guide sequence 
Transfection Ampicillin 
Optimization 
Up-regulation experiments Kanamycin 
Up-regulation experiments Kanamycin 
Up-regulation experiments Ampicillin 
Up-regulation experiments Ampicillin 
Up-regulation experiments Ampicillin 
Down-regulation experiments Ampicillin 
Down-regulation experiments Ampicillin 
Down-regulation experiments Ampicillin 
3.1.6. Tissue Culture 
MCF-7 and SKOV3 cells were cultured as described previously. For MTT assay 
experiment and Ribonuclease Protection Assays, MCF-7 cells were cultured as 
previously described except that 17-(3-estradiol (2nM) and insulin (litg/ml) (Sigma) were 
included in the media and cells were passaged at least 3 times upon reviving before they 
were used for experiments. 
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3.1.7. (3-Galactosidase Staining and Transfection Optimization 
MCF-7 or SKOV3 cells were plated into 30mm wells with 3.0xl05 cell in each 
well using media with no antibiotics and incubated overnight at 37°C 5%CC>2. The 
following day, the cells were transfected with 0, 2, 4.5, 7, 9.5, or 12 ug of 
pcDNA3.1/His/LacZ using the Lipofectamine 2000 reagent protocol (Invitrogen) using 
OPTI-MEM (Gibco, Grand Island NY) and 8ul of Lipofectamine 2000 for each well. 36 
hours later, the transfected cells were stained using the P-Gal Staining Kit (Invitrogen) as 
described in the |3-Gal Staining Kit Manual, Version G. Following staining, the center of 
the well was photographed and the cells were rinsed with PBS pH 7.2 (Gibco) and 
resuspended into lmL Dimethyl Sulfoxide (DMSO) (Sigma, St. Louis MO). The 
suspension was incubated at 50°C for 1 hour with vortexing every 5 minutes. The debris 
was pelleted by centrifugation (13200rpm, 10 minutes) and the supernatant was measured 
on a spectrophotometer at 595nm. 
3.1.8. Transfections 
Cells were plated (3xl05 cells/well) into 6-well plates in a final volume of 2mL of 
growth medium. The next day, cells were transfected as described in the Lipofectamine 
2000 Reagent transfection procedure for DNA (Invitrogen). Briefly, 7ug of appropriate 
plasmid was diluted into 250ml of OPTI-MEM (Gibco) and 8ul of Lipofectamine 2000 
(Invitrogen) was diluted into 250ul Opti-MEM (Gibco). Five minutes later, the volumes 
were then combined and allowed to incubate at room temperature for 20 minutes. The 
transfection mix was then added to the 6 well plates and the transfected cells were placed 
at 37°C, 5%C02 until lysis. If cells were transfected in 96 well plates, 104 cells were 
plated into each well into a final volume of 200ul of growth medium. The following day 
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the tranfection mix was prepared as described above and 50JJ1 of die mix was added into 
each well. 
3.1.9. Cell Lyses and Protein Quantification 
Cells were lyzed and the total protein was quantified using either the Cell Lysis 
and Protein Quantification of Cell Lines protocol (Chapter 2, Section 2.1.2) or the Cell 
Lysis and Protein Quantification of Tissue Samples protocol (Chapter2, Section 2.1.3) 
that was previously described. 
3.1.10. Western Analysis 
Western analysis for FLAG-tagged protein expression was done as previously 
described (Chapter 2, Section 2.1.5). The primary antibody used was mouse-anti-FLAG 
(Stratagene) and secondary antibody used was anti-mouse IgG (Promega). 
3.1.11. MTT Assays for Cell Survival 
Before plating, cells were examined with Trypan Blue staining to ensure >90% 
viability. Cells were plated into 96well plates (10000 cells/well) and transfected with 
either pCMVXL5, pCMVXL5-Stxl8 or pCMVXL5-Stxl8ATM. Each well was 
transfected with 0.5ul of lipofectamine 2000 and 0.35p.g of plasmid into a total volume of 
50ul OPTI-MEM. Wells with no cells were filled with growth medium to prevent 
evaporation of inner wells. Plates were placed in the incubator for 24, 48, 72, 96 or 120 
hours. At the appropriate time-point, 50ul of media was removed and replaced with 50ul 
of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma) 
(lmg/ml) and the plate was placed in the 37°C, 5%CC>2 incubator for 4 hours. 210ul of 
medium and MTT salt was removed from each well and replaced with 150ul of DMSO 
(Sigma) and agitated on a plate shaker for 10 minutes. Absorbance at 570nm was then 
read on a plate reader. 
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Alternatively, for the 120 hour MTT assay with E2 and insulin, cells were plated 
into 6 well plates and transfected as previously described. 24 post-transfection the cells 
were trypsinized and plated into 96 well plates at 10000 cells/ well. A standard MTT 
assay was conducted for 24,48,72,96 and 120 hours post-plating. 
To generate a standard curve, MCF-7 or SKOV3 cells were plated at varied 
densities (300000, 200000, 150000, 100000, 50000, 25000, 5000, 2500, 0 cells/well) in 
quadruplicate. The following day, three replicates were assayed as described above. The 
cells in each well of the final replicate were counted using a hemacytometer. A standard 
curve was generated by ploting the absorbance at 570nm vs the log(Cell #). 
3.1.12. Production of Internally Labeled Probe for use in RNase Protection Assay 
Internally labeled probed was generated using T7 RNA polymerase or SP6 RNA 
polymerase directed in vitro transcription of templates downstream of the T7 promoter. 
Briefly, each reaction contained lx transcription buffer (Promega), lOmM DTT (final 
concentration), RNasin (lU/ul), 0.5mM ATP, CTP and GTP, 12.5uM UTP, 50uCi of 
32P-UTP (Amersham Biosciences), 0.5ml DEPC H20, 100-300ng linear DNA template 
and 15 units of T7 RNA Polymerase (Promega). Mixture was then incubated at 37°C for 
1 hour. lOul of RNase free DNasel (lU/ui) was added and the mixture was incubated 
for an additional 10 minutes at 37°C. 
If the probe was to be gel purified, it was run on a 12% denaturing 
polyacrylamide 8M urea gel and visualized using a Cyclone Storage Phosphor Screen 
System (Packard, Meriden CT). By using a printed full-size overlay, the section of gel 
containing full length probe was excised and placed into probe elution buffer (7.5M 
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NH4OAc, 0.5M EDTA pH8, 20% SDS, 1 volume phenol/chloroform) for 6 hours, with 
vortexing every 30 minutes. 
Following elution of the probe, RNA was purified using standard 
phenol/chloroform extraction and ethanol precipitation described earlier. Precipitated 
probe was re-suspended into lOOul of DEPC-H20 and its activity in counts per minute 
(cpm) was determined using a Packard 1600 TR liquid scintillation counter. Internally 
labeled probe was stored at -20°C until use. 
If the probe was not gel purified following the in vitro transcription reaction 
probe, it would be subjected to standard phenol/chloroform extraction and precipitated by 
standard ethanol precipitation. In short, 1/10 volume of 5M NH4OAC (Ambion) and 2 
volumes of ethanol were added to the RNA and the sample was incubated at -20°C for 1 
hour. Precipitated RNA was pelleted by centrifugation (13200rpm, 4°C, 15 minutes) and 
washed twice with 70% ethanol. Pellet was dried and resuspended into 50ul DEPC-H2O. 
Radio labeled probe was then heated to 65°C and spun through a ProbeQuant G-50 micro 
column (Amersham Biosciences). Activity was measured as previously described and 
probe was stored at -20°C until use. Template plasmids and probe sequences used in the 
RPA assays are outlined in Table 4. 
Table 4. Vectors and Probe Information for Probes Used in the Ribonuclease 
Protection Assays 
Plasmid Construct 
pTRI-P-Actin-125-
Human antisense 
Control Template 
Linearized 
with 
Xbal/Hindlll 
Enzyme Used In 
Transcription 
Sp6RNA 
Polymerase 
T7RNA 
Polymerase 
Size of Probe 
245 nts 
197 nts 
Size of Protected 
Fragment 
181 nts 
127 nts 
pUC 19-CRD-myc-1705 -
1886 
EcoRI 
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3.1.13. Isolation of total RNA for Ribonuclease Protection Assays 
MCF-7 cells were transfected in 6 well plates with either pCMV-XL5, pCMV-
XL5Stxl8, or pCMV-XL5Stxl8ATM as previously described. RNA was isolated 0, 24, 
48 or 72 hours post transfection using Trizol reagent as per manufacturers protocol 
(Gibco). Briefly, cells were lysed using 1ml of Trizol for 5 minutes at room temperature. 
200ul of chloroform: isoamyl alcohol (49:1) (Sigma) was added to the Trizol and the 
samples were shaken vigorously for 15 seconds. Phases were separated by centrifugation 
(12,000g for 15 minutes) and the aqueous layer was extracted. RNA was precipitated 
using 500ul of isopropyl-alcohol and pelleted by centrifugation (12,000g for 10 minutes, 
4°C. RNA was washed with 75% EtOH and resuspended in 100ui of DEPC-treated H20. 
Isolated RNA was quantified on a NanaDrop ND-1000 spectrophotometer (NanaDrop 
Technologies, Wilmington DE). Purified RNA was stored at -80°C until ribonuclease 
protection assay. 
3.1.14. Ribonuclease Protection Assay 
Ribonuclease protection assays were carried out using the RPA III kit according 
to the manufacturers protocol (Ambion). In short, 20 or 30 \xg of total RNA was co-
precipitated with either l-3xl05 cpm of c-myc probe or 104 cpm of P-actin probe and 
resuspended in lOul of hybridization buffer (Ambion, Austin TX) and incubated at 42°C 
overnight. The following day, samples were digested with RNaseA/Tl (Ambion) diluted 
to the appropriate concentration in RPA digestion buffer (1/100) (Ambion). Samples 
were then ethanol precipitated and the pellet was resuspended in 4ul of loading dye 
(Ambion). Samples were run on a 6% polyacrylamide 8M urea gel at 25mA for 
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approximately 1 hour. Gel was then dried for 1 hour and visualized using a Cyclone 
Storage Phosphor Screen System (Packard). 
3.2. Results and Discussion 
3.2.1. Transfection Optimization Using P-Gal Expression Assay 
Initially, transfections were done using lOul of Lipofectamine 2000 reagent in 
each well; however, this appeared to be toxic to the cells as the culture exhibited loss of 
adherence. Once the volume of Lipofectamine 2000 reagent was reduced to 8ul, while 
the plasmid DNA concentration remained constant, the culture appeared to be much 
healthier. Once the volume of transfection reagent was established, it was necessary to 
determine the amount of plasmid that would result in optimal transfection efficiency. In 
order to do this, a P-galactosidase staining kit (Invitrogen) was used. Cells were plated 
and transfected once they reached 90% confluency, with varying amounts of plasmid. 36 
hours later, they were stained using the P-gal staining protocol. Cells were then dissolved 
into DMSO, spun down, and the supernatant was quantified on a spectrophotometer. 
Since the product of the LacZ gene catalyses the hydrolysis of X-gal resulting in a blue 
colour, a higher absorbance at 595nm means that more product was present from the 
LacZ gene product. The results if this experiment can be observed in Figure 11. 
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Figure 11. The results of the p-galactosidase staining experiment. (A) A graph 
representing the amount of p-gal staining in 106 cells relative to the jag of plasmid 
transfected in MCF-7 and SKOV3 cells lines. Error bars represent the standard 
deviation of 4 replicates. (B) The MCF-7 cells as seen through an Olympus SZ61 
dissecting microscope at 45X magnification. Values under the photos are of the amount 
of plasmid used in the transfection of that particular well. Blue staining is indicative of 
successful transfection. (C) The SKOV3 cells as seen through an Olympus SZ61 
dissecting microscope at 45X magnification. 
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From Figure 11, it can be observed that both cell lines follow a similar trend. The 
most P-galactosidase product resulted when 7.0ug of plasmid was transfected, with a 
reduced amount of product being generated when more or less plasmid was used. Since 
more product was generated at 7.0p,g of plasmid, then the LacZ gene must have been 
present and expressed more efficiently. Therefore, in subsequent experiments described 
in chapter 3 and 4, the best results would be obtained when 7.0ug of plasmid is used. 
Interestingly, the MCF-7 cells appeared to be easier to transfect than SKOV3 cells 
as observed by higher absorbance for every 106 cells. MCF-7 cells peak at an absorbance 
of 0.49 while SKOV3 cells peak at 0.26. This is possibly indicative of a lower 
transfection efficiency of the SKOV3 cell line. In fact, Invitrogen mentions successful 
transfection of MCF-7 cells with Lipofectamine2000 reagent, while they report 
successful transfection of SKOV3 using the original Lipofectamine reagent (Invitrogen, 
2007). The lower transfection efficiency could result in difficulty in expressing or 
knocking down Syntaxinl8 as described in the following two Aims. In fact, this was the 
case for achieving gene knockdown in the SKOV3 cell line. 
3.2.2. Plasmid Purification 
Plasmid constructs were transformed into DH5a E.coli cells and the transformed 
bacteria were grown on selective agar plates. As expected, colonies were observed on the 
plates, indicating that transformation was successful. Upon selection and propagation of 
a single transformed colony, the plasmid DNA was purified. Purified DNA was 
restriction digested to ensure that the proper plasmid was present. Results of the 
restriction digest analysis can be seen in figure 12. 
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A B 
Figure 12. Purified expression vectors used in Aim II. (A) 1% agarose gel showing 
the pCMV-Tag2 expression vector undigested (lane 2) and digested with Xhol and Pstl 
(lane 3), as well as the pCMV-Tag2-Stxl8 vector undigested (lane 4) and digested with 
Xhol and Pstl (lane 5). (B) 1% agarose gel showing the restriction digests of pCMV-
XL5 (lanes 2-4), pCMV-XL5-Stxl8 (lanes 5-7) and pCMV-XL5-Stxl8ATM (lanes 8-
10). 
As expected, the digestion of pCMV-Tag2a empty vector with Xhol and Pstl 
resulted in linearization of the plasmid due to the presence of each restriction site within 
the MCS of the plasmid (Figure 12A, lane 3). The plasmid size was confirmed as the 
linear plasmid migrated to the expected size of approximately 4.3kb when compared to 
the ladder. The linear plasmid also showed different migration than its supercoiled form 
(lane 2). Also, two additional bands can be observed in the undigested plasmid, 
representing the coiled and nicked conformations of plasmid DNA. The digestion of 
pCMV-Tag2A-Stxl8 showed similar results with the exception that the Six 18 cDNA 
insert was released from the plasmid during the digestion and migrated further down the 
gel at approximately 1.2kb (Figure 12A lane 5). 
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The digestion of pCMV-XL5 with EcoRI and Xbal resulted in the linearization of 
that plasmid, which showed an expected size of approximately 4.5kb (Figure 12B lane3). 
Digestion of the same plasmid with BamHI had no effect as expected, due to the absence 
of this restriction site in the plasmid. Digestion of pCMV-XL5-Stxl8 with EcoRI and 
Xbal expectedly released the Stxl8 cDNA, which can be seen at approximately 1.6kb 
(Figure 12B lane 6). This sequence was longer than the cDNA contained in pCMV-
Tag2A-Stxl8 because it contained the 3'UTR whereas the latter plasmid was lacking it. 
Digestion of this plasmid with BamHI resulted in linearization due to the presence of one 
BamHI site within the Stxl8 cDNA. The digestion of pCMV-XL5-Stxl8ATM 
(Figurel2B lanes 8-10) also exhibited the expected results. Double digestion of the 
plasmid (lane 9) resulted in linearization. This is because during the removal of the 
transmembrane domain from the original clone, the Xbal site was destroyed while the 
EcoRI site was preserved. The digestion with BamHI had no effect as this site was 
removed during the removal of the transmembrane cDNA. Also, the migration of 
pCMV-XL5-Stxl8ATM was observed to be in between those of the other two plasmids 
(pCMV-XL5 and pCMV-XL5-Stxl8), which is consistent with expectations. 
3.2.3. FLAG-Tag-Syntaxinl8 expression in MCF-7 and SKOV3 cells. 
MCF-7 and SKOV3 cells were made to express FLAG-tagged syntaxinl8 through 
transfection with pCMV-Tag2-Stxl8 vector. This vector was used to monitor the success 
of up-regulating Syntaxinl8 due to the availability of commercial antibodies, making 
detection of the recombinant fusion protein easy. The selected vector was also used 
because the expression of the protein is under the CMV promoter, the same promoter as 
the XL5 expression vector. Experiments depicting the successful transfection and 
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subsequent expression of the syntaxinl8 fusion protein within MCF-7 and SKOV3 cells 
can be seen in Figure 13. 
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Figure 13. Expression of FLAG-tagged syntaxinl8 within MCF-7 and SKOV3 cells. 
(A) An immunoblot of MCF-7 cell lysate with different amounts of total protein loaded. 
Cells were lysed 48 hours following transfection. (B) An MCF-7 time-course 
experiment showing the expression of FLAG-tagged syntaxinl8 over a 96 hour period. 
(C) A western blot illustrating the successful expression of FLAG-tagged protein in 
SKOV3 cells. Cells were lysed 48 hours following transfection. 
Figure 13 A shows the successful transient expression of the FLAG-tagged protein 
in MCF-7 cells at 48hours. Also, as expected, the FLAG epitope is only present at a size 
of about 35-50kDa in lanes containing lysates transfected with pCMV-Tag2-Stxl8, while 
the p-actin blot confirms that there was protein contained in all lanes. Also, the protein 
containing this epitope ran at ~40kDa, consistent with the expected size of Syntaxinl8. 
Another objective of this experiment was to determine the optimal amount of total 
protein to load within a lane. 25, 15 and 5ug of total protein was loaded in lanes 3,4,5 
respectively. From the data, it is clear that 25(j,g of total protein is required for the best 
detection of FLAG-Stxl8 fusion protein. 
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It was of interest to determine for how long after the initial transfection the tagged 
protein would be expressed. To investigate this, MCF-7 cells were transfected with 7jj,g 
of the plasmid and harvested at 4 different time points being 24, 48, 72 and 96 hours 
post-transfection. The cells transfected with the negative control were harvested 48 hours 
post-transfection, as this time point was already shown to exhibit transient gene 
expression. The results of this experiment are depicted in Figure 13B. It was observed 
that the FLAG epitope was maximally expressed at 48 hours and can be detected in cell 
lysates for as long as 96 hours post-transfection. However, after 72 hours there appears 
to be a decline in expression. This is most likely due to the diluting effect proliferating 
cells has on the expression vector, with a higher proportion of the population containing 
no expression vector at later time points. Alternatively, the episomal plasmid may not 
remain in the nucleus during the entire 96 hours of the experiment. Nevertheless, this 
result confirms that protein will be expressed for an acceptable duration of time after the 
cells are transfected, and the MTT assays to examine cell survivability and growth can be 
conducted over a 96 hour period. 
In addition to MCF-7 cells, positive confirmation of transfection of the other cell 
line used in this study, SKOV3, needed to be obtained. As can be seen in Figure 13C, the 
SKOV3 cells exhibited transient gene expression of FLAG-tagged Syntaxinl8. Again, 
only the lane transfected with vector containing the syntaxinl8 cDNA showed an affinity 
for the FLAG antibody, while all three lanes contained p-actin. This result demonstrates 
that even though the SKOV3 cells appeared to be more difficult to transfect, as examined 
with (3-gal staining (previous chapter), enough cells were transfected to obtain 
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measurable levels of recombinant protein. The success of this experiment means that it 
would be worth running an MTT assay on the SKOV3 cell line in addition to MCF-7. 
3.2.4. Cell Survivability Assays 
In order to investigate the effect of up-regulation syntaxinl8 on cell survivability 
and growth, MTT assays were employed. During this assay, metabolically active cells 
convert yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
into purple formazan within their mitochondria, therefore the number of live cells is 
directly related to the total amount of formazan produced. In fact, this technique has 
been used by another group to examine the anti-proliferative effects of recombinant 
caspase3 on a gastric tumor derived cell line SGC7901 (Fu et al. 2003). 
In order to directly correlate the absorbance of purple formazan to the total 
number of cells present, a standard curve was produced by plating untransfected cells at 
different densities and then running a standard MTT assay. Also, it was necessary to 
count replicate wells, as the total number of cells present during the MTT assay would be 
different than the amount originally plated. The standard curve for each cell line, MCF-7 
and SKOV3, can be seen in Figure 14. 
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Figure 14. Standard curves used to calculate total cell number during MTT assays. 
(A) The standard curve generated by different densities of MCF-7 cells subjected to an 
MTT assay. (B) The standard curve generated by different densities of SKOV3 cells 
subjected to an MTT assay. Cells were plated at different densities and subjected to an 
MTT assay 24 hours later. Replicated wells were counted using a hemocytometer. Error 
bars represent the standard deviation of 3 independent samples. 
Both MCF-7 and SKOV3 cells were transfected with expression vector in order to 
investigate whether an increase in Syntaxinl8 has an effect of cell survivability and 
proliferation. The results of these experiments can be seen in Figure 15. 
From Figure 15, it can be observed that up-regulated Syntaxinl8 levels has no 
effect on cell survivability or proliferation for either cell line tested (pCMV-XL5 
compared to pCMV-XL5Stxl8). This is evidenced by the almost identical growth 
observed in each of these two treatments for both cell lines. However, it can be observed 
that in the MCF-7 cells transfected with the vector expressing the truncated protein, there 
is an inhibition of growth seen between 24 and 48 hours post-transfection (Figure 15A). 
This appears to correct itself after 48 hours and the final cell density is equal to that of the 
other two treatments after 96 hours. Also, this trend is observed again in the SKOV3 cell 
line, although cells expressing the truncated protein do not appear to proliferate at all 
while the cells expressing the full length protein and no protein do proliferate over 72 
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hours, but then a significant amount of cell death is seen as the population loses density 
(Figure 15B). 
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Figure 15. MTT assay showing the effect of recombinant syntaxinl8 expression on 
the survivability of MCF-7 and SKOV3 cells in culture. (A) Comparative MTT assay 
between MCF-7 cells transfected with pCMV-XL5 (solid line), pCMV-XL5Stxl8 
(dashed line) and pCMV-XL5Stxl8ATM (bold dashed line). (B) Comparative MTT 
assay between SKOV3 cells transfected with pCMV-XL5 (solid line), pCMV-XL5Stxl8 
(dashed line) and pCMV-XL5Stxl8ATM (bold dashed line). Error bars are the standard 
deviation of 4 replicates. The figure is representative of three trials. 
It may be possible that Stxl8 can act to cleave mRNA in live cells just as it does 
in vitro. However, perhaps when it is anchored to the ER membrane its access to 
substrate is restricted. This would explain why there is no observable difference between 
the cells expressing full length recombinant Stxl8 and the negative control. This might 
also serve to explain what is observed in the cells expressing the truncated protein. These 
cells are expressing Stxl8 with a deletion of its trans-membrane domain. Therefore, the 
recombinant protein is not anchored to a membrane and might have greater access to 
transcripts. Should Stxl8 cleave a transcript important to cellular proliferation, such as c-
myc, then the gene would be silenced and an anti-proliferative effect would be observed 
(Wang et al. 2005). In order the confirm differential localization of the full-length Stxl8 
protein and the truncated, trans-membrane deleted protein, one could transfecte MCF-7 
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cells with a pGFP-Stxl8 or pGFP-Stxl8DTM vector. You could then examine the 
fluorescence of the Green Fluorescence Protein (GFP) in cells to confirm differential 
localization. 
Even though there appears to be a period of reduced proliferation in MCF-7 cells 
expressing the truncated protein (24-48 hours), proliferation greatly accelerates over the 
next 24 hours. One possible explanation for this is that over time a higher proportion of 
the cells do not posses expression vector and are therefore not inhibited in their 
proliferation. Due to the initial slow growth of the culture there may an abundance of 
nutrients allowing the cells to proliferate quickly. This is also supported by the fact that 
all three treatments show reduced proliferation between 72 and 96 hours, most likely due 
to lack of sufficient nutrients and an acidic environment. 
Lack of proliferation in the SKOV3 cells expressing the truncated protein may be 
due to similar reasons as outlined for the MCF-7 cell line. However, since SKOV3 has a 
doubling time of 32 hours as opposed to that of MCF-7, which is 37 hours; one would 
expect that the restriction in growth would occur sooner and the plasmid would be diluted 
out faster in SKOV3 than MCF-7. This does not appear to be the case as the reduced 
proliferation can be seen between 48 and 72 hours post-transfection compared to between 
24 and 48 hours for MCF-7 cells. The lag in anti-proliferative effect may be a result of 
the seemingly lower transfectability of the SKOV3 cells when compared to MCF-7 
(Figure 11). Since lower transfectability means less plasmid is present from which the 
truncated protein can be generated, it may take longer for the transiently expressed 
protein to be present in sufficient concentrations to effect a change. 
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As will be seen in the following chapter, knockdown of Stxl8 in SKOV3 cells 
was less successful than silencing the gene in MCF-7 cells. Due to the apparent higher 
success rate and better transfectability of the MCF-7 cell line, it was decided that this cell 
line would be examined in greater detail using MTT assays. Since MCF-7 is an estrogen 
receptor positive cell line and shows increased levels of c-myc transcript upon estrogen 
exposure (Rodrik et al. 2005; Mawson et al. 2005), it was thought that the anti-
proliferative effect of syntaxinl8 might be exaggerated when cells were co-incubated 
with 17-P-estradiol (E2). Also, this would allow the c-myc levels to be easily detectable 
when examining mRNA. Therefore, several MTT assays were conducted in the presence 
of E2 and insulin, another molecule that can aid in cell cycle progression (Mawson et al. 
2005). The results of this experiment can be seen in Figure 16. 
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Figure 16. A comparative MTT assay showing the effect of up-regulating 
syntaxinl8 in MCF-7 cells in the presence of E2 and insulin. Cells were transfected 
with negative control (solid line), full length Stxl8 expression vector (dashed line) or 
truncated syntaxinl8 expression vector (bold dashed line). Error bars are the standard 
deviation of 4 independent replicates. This figure is representative of duplicate trials. (*) 
ANOVA analysis shows significance at the p=0.01 level. 
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In addition to incubating the cells with E2 and insulin, it was thought that since 
the culture had been growing in the 96 well plate for 48 hours before the first MTT assay 
was conducted, the cell may not have room to propagate due to crowded conditions. 
Also, since over expression of Stxl8 did not seem to affect survivability it was of more 
interest to focus on proliferation. As a result, cell were transfected in 6 well plates and 
re-plated into 96well plates once they were expressing the recombinant protein. This 
would allow the transfected cells to grow without the negative impact of overcrowding. 
As can be seen in Figure 16, the cells are present at a much lower density during 24 hours 
then the previous experiment. Also, the cells proliferate exponentially as expected. 
Although over-expression of Stxl8 does not seem to compromise survivability of 
the culture, it does seem to impact proliferation rates. Figure 16 shows that cells that 
express the full-length protein show slower propagation than the negative control until 96 
hours, where the effect is reversed. Similarly, the cells expressing the truncated protein 
also showed a retarded rate of growth when compared to the negative control up to 96 
hours. However, by this point the expression vector has most likely been diluted out and 
the Stxl8 expressing cells rebound. In the negative control, cells are starved for space 
and nutrients and begin to develop a negative population growth rate. 
One explanation for the decreased proliferation might be for the reasons described 
previously. That the recombinant protein is digesting mRNAs important to cell cycle 
progression in the same manner that it digests c-myc mRNA in vitro. Previously the full 
length protein was not effective in reducing proliferation while its truncated counterpart 
had some effect. However, Figure 16 shows each protein affecting the proliferation of 
MCF-7 cells. It might be possible that since the c-myc transcript is present in greater 
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concentrations due to the influence of E2, and due to its localization at the perinuclear 
cytoplasm (Chabanon et al. 2005), enough c-myc mRNA may come into contact with full 
length Stxl8 to show a difference when compared to the control. 
Another possible explanation for the decreased proliferation is the effect of ER 
aggregation caused by an increase in Stxl8 (Hatsuzawa et al. 2000). ER aggregation may 
induce the ER stress response (Szegezdi et al. 2006). ER stress has been shown to inhibit 
cyclinDl (Zhao et al. 2006). Since this molecule is present in greater amounts due to 
incubation of the cells with insulin (Mawson et al. 2005), it is plausible that it is the 
effect of ER stress reducing the levels of cyclinDl, and therefore indirectly reducing the 
rate of proliferation, that we are observing in this experiment. 
3.2.5. Ribonuclease Protection Assays for c-myc and fi-actin mRNA 
In order to investigate whether syntaxinl8 affects the steady state mRNA levels 
and stability of transcripts in MCF-7 cells, the method of ribonuclease protection assays 
was employed. The transcripts investigated in this study were c-myc and fi-actin 
mRNAs. Recombinant Syntaxinl8 has been shown to cleave c-myc mRNA in vitro 
(Urquhart, 2006); therefore, if levels of the c-myc transcript were affected in MCF-7 cells 
upon modulation of Stxl8, there would be compelling evidence of a possible function of 
Stxl8 as an endoribonuclease in live cells. For this reason, the c-myc transcript was 
investigated in this series of experiments. Also, due to its naturally stable nature, which 
is in stark contrast to the c-myc transcript, the /3-actin transcript was chosen as the other 
mRNA to be investigated. 
Generation of the probes used in the ribonuclease protection assays were done 
using an internally labeling in vitro transcription reaction driven by the T7 or SP6 RNA 
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polymerase promoter. One probe used in there experiment was generated to protect a 
fragment of the c-myc transcript while the other was targeting the P-actin transcript. 
Optimization experiments used non-gel purified probe, while other experiments 
warranted further purification of the probe. Probes to be purified were run on a 
denaturing 12% polyacrylamide gel, visualized and then the highest molecular weight 
bands were excised. The gel was visualized a second time to ensure that the proper area 
of the gel was extracted. This is illustrated in Figure 17. 
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Figure 17. The gel purification of internally labeled c-myc and p-actin probe used 
in Ribonuclease Protection Assay experiments. (A) Audioradiograph of a denaturing 
12% polyacrylamide gel illustrating the products of the internal labeling in vitro 
transcription reaction, p-actin full length probe is 192nts long while the full length c-myc 
probe is seen at 245nts. (B) Audioradiograph of the gel depicted in (A) with the pertinent 
radio-labeled fragments excised from the gel. 
Some optimization experiments using RNase protection assays were required 
prior to using the assay to accurately measure the levels of c-myc and P-actin mRNA in 
MCF-7 cells. All of the yeast RNA controls were run and a series of dilutions of 
RNaseA/Tl were examined to determine which would be the best concentration of 
ribonuclease to use in subsequent experiments. The results of these tests can be seen in 
Figure 18. 
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As expected, when each probe was incubated in hybridization buffer with 30p,g of 
yeast RNA, no protection occurred. Samples that were subsequently incubated in 
digestion buffer that contained RNaseA/Tl showed no bands to indicate the presence of 
protected RNA (Figure 18A, lanes 4 and 6). This background control shows that the both 
the c-myc and (3-actin probes will not protect themselves increasing confidence that and 
bands observed are due to the presence of the target transcript. Also, samples that were 
incubated in digestion buffer that did not contain RNaseA/Tl still had bands present after 
digestion (Figure 18A, lanes 5 and 7). This is a clear indication that digestion of the 
samples is in fact due to the presence of the RNase A/Tl and not some contaminating 
factor within the buffers. 
To determine the optimal dilution of RNaseA/Tl, 30ug of total RNA extracted 
from MCF-7 cells was hybridized to 1-3 xlO5 cpm of c-myc probe or 104cpm of p-actin 
probe overnight. The unhybridized RNA was then subjected to digestion with 
RNaseA/Tl in a 1/50, 1/100 or 1/300 dilution. Protected fragments were then run on a 
12% denaturing polyacrylamide gel and visualized. The results can be seen in Figure 18 
B. Upon visualization of this experiment, there appeared to be no difference between any 
of the three dilutions when the c-myc antisense RNA probe was protected by transcript 
(Figurel8B, lanes 4-6). This indicates that the concentration of the ribonucleases was 
sufficient to facilitate digestion of the unprotected RNA at a 1/300 dilution. Also, no 
obvious digestion of protected fragments was observed when the probe was 6X more 
concentrated at a 1/50 dilution. Using this data, and taking the recommendation of the 
manufacturer, a 1/100 dilution of RNaseA/Tl in digestion buffer was used in subsequent 
experiments. 
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Figure 18. Control and optimization experiments for ribonuclease protection 
assays. (A) Audio radiograph of a RPA experiment showing yeast RNA controls. 
Samples were allowed to hybridize overnight and then incubated in digestion buffer in 
the presence or absence of RNaseA/Tl (B) Audio radiograph of optimization experiment 
to determine optimal dilution of RNaseA/Tl in digestion buffer. Both A and B utilized 
30|ng of total RNA and approximately 1-3 xlO5 cpm of c-myc probe and 104cpm of P-
actin probe. The 88nts c-myc CRD nts 1705-1792 was used as another size marker and 
was generously donated by Tavish Barnes. 
Protection of the c-myc probe by transcript interestingly resulted in the 
appearance of 2 major bands. RNA is an unstable class of molecule and extra bands 
observed are likely due to degradation of the probe or sample RNA. In fact, due to the 
unstable nature of RNA, a small amount of background banding is expected in RPA 
experiments (BDbiosciences, 2007). It is likely that the highest band is the protected c-
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myc probe as it is seen around the expected size of ~188nts. The other bands observed at 
around 130nts may be probe that is protected but was slightly degraded before it 
hybridized to its target mRNA. Alternatively, the lower band might represent a 
degradation product of the c-myc transcript itself. The probe does target a region with 
the CRD of the c-myc transcript and is known that the CRD of c-myc is cleaved by an 
endoribonuclease (Ross et al. 1995). It is possible that the extra band observed is a 
cleavage product of the c-myc transcript. However, upon observing the naked probe 
(Figure 18B, lane 2), a band of increased intensity can be seen at around 225nts. It is 
possible that this band is degraded probe that still posses the ability to hybridize to the 
sample RNA. The truncated probe may be protecting the transcript, resulting in the 
appearance of the bands at 130nts. Extra bands can also be observed in the samples 
protected by the P-actin probe (Figure 18B, lanes 7-9). These bands are also likely due to 
a slight degradation of the probe resulting in background banding. 
To investigate the effect of up-regulating Stxl8 on the steady state levels of c-myc 
and fi-actin mRNA, MCF-7 cells were transfected with Stxl8 expression vectors and 
RNA was expected at 24, 48 and 72 hours. RNA showing a 260/280 ratio between 1.85 
and 2.0 were deemed of acceptable quality and were used. The ribonuclease protection 
assay was run and the results can be seen in Figure 19. 
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Figure 19. Ribonuclease Protection Assay showing steady state mRNA levels of c-
myc and fi-actin in samples where Stxl8 was up-regulated. MCF-7 cells that were 
grown in the presence of E2 and insulin were transfected with either pCMV-XL5, 
pCMV-XL5Stxl8 or pCMV-XL5Stxl8ATM and RNA was extracted at 24, 48 and 72hrs 
post-transfection. 20ug of total RNA was hybridized to 1-3 X105 cpm of gel purified c-
myc probe and 104 cpm of gel purified (3-actin probe. Upon hybridization, un-protected 
RNA was digested with RNaseA/Tl in digestion buffer (1/100) and run on a 6% 
denaturing polyacrylamide gel. The gel was then dried and visualized. 
From Figure 19, it appears that up-regulation of Stxl8 has no apparent effect of 
the steady state levels of the c-myc transcript. This is because the band representing the 
protected c-myc fragment follows the same pattern as the (3-actin bands. For examples, 
we see a reduction of c-myc in lane 8 and 9, but we see a similar effect on the (3-actin 
probe in the same lanes. Assuming that the modulation of Stxl8 has no effect on the 
steady state levels of /3-actin, than it could act as an effective loading control. This would 
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mean that the decrease in c-myc levels with the samples transfected by pCMV-XL5Stxl8 
and pCMV-XL5Stxl8ATM (Figure 19, lanes 8 and 9) are due to differences in recovery 
when processing the sample. Also, this experiment is representative of several 
ribonuclease protection assays that were conducted on the same sample. Each trial 
showed similar changes with respect to the level of c-myc and /3-actin mRNA present. 
If up-regulation of Stxl8 does affect the steady state levels of /3-actin, then it 
could not function as a proper loading control. In this case, it would appear that up-
regulating Stxl8 results in a reduction of both c-myc and {3-actin mRNA at 48 hours 
(Figure 19, lane8). Transfection with the truncated protein has an even greater effect of 
reducing the levels of these transcripts at 48hours (Figure 19 lane 9). However, multiple 
ribonuclease protection assay experiments were conducted on the same set of samples 
and a similar pattern was observed. At this point it is impossible to tell whether up-
regulating Stxl8 has a de-stabilizing or down-regulation effect on both the c-myc and 
/3-actin transcripts. However, if it does, then we seem to observe a correction after 72 
hours. If /3-actin and c-myc mRNAs are affected, then an appropriate loading control 
consisting of a transcript that has no change upon modulation of Stxl8 would be 
desirable to normalize the other transcripts. 
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Chapter 4 
The Effects of Down-Regulation of Syntaxinl8 on Cell Survival 
and c-Myc Gene Expression 
This chapter aimed at investigating the effects of down-regulating syntaxinl8 on 
cell survival and c-myc gene expression. This chapter will describe the methods used in 
achieving this aim, as well as the results obtained. The relevant results and their 
significance in relation to the research question will be discussed. 
4.1. Materials and Methods 
4.1.1. Tissue Culture 
MCF-7 cells were cultured as described previously. For 120 hour MTT assay 
experiment and Ribonuclease Protection Assays, MCF-7 cells were cultured in the 
presence of 17-P-estradiol (2nM) and insulin (lug/ml) (Sigma) as previously described. 
4.1.2. Transfections With Small Interfering RNA From Ambion 
Three siRNA sequences were designed by Ambion to knockdown syntaxinl8. 
These sequences are outlined in Table 5. MCF-7 cells were transfected with siRNA 1, 
siRNA 2 or siRNA 3 (Ambion) using siPORT amine transfection reagent (Ambion) as 
per manufacturers protocol. Briefly, 8ul of transfection reagent was diluted into 92(4.1 of 
OPTI-MEM (Gibco) and incubated at room temperature for 10 minutes. 3.75ul of 
siRNA (20mM) was diluted into 96.25ul of OPTI-MEM and this solution was combined 
with the siPORT amine solution. The mixture was allowed to incubate at room 
temperature for 10 minutes and then it was dispensed into one well of a six well plate. 
MCF-7 cells were then plated into the well, using previously described growth medium, 
at a density of 3xl05 cells/ well. Transfected cells were placed in the 37°C 5%CC>2 
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incubator for 48hours until lysis. An additional well containing cells transfected with 
GAPDH siRNA was included as a positive control. A well containing cells transfected 
with negative control siRNA was included as a negative control. 
4.1.3. Transfections With Dicer Substrate siRNA 
Three dicer substrate siRNA molecules (siRNA 4, siRNA 5, siRNA 6) were 
designed using SciTools RNAi Design tool from Integrated DNA Technologies Inc. 
Sequences were designed to target NCBI ID# AB028741. Sequences used in 
transfections are outlined in Table 5. The region of the Stxl8 transcript where the 
siRNAs are targeting are depicted in Figure 20. MCF-7 cells were transfected using 
Lipofectamine 2000 reagent protocol previously described. A final siRNA concentration 
of 30nM was used in each well. Also, one well was transfected with all three siRNAs 
together at a concentration of 30nM each. (3-actin siRNA (Ambion) and a negative 
control siRNA (IDT) were used as positive and negative controls respectively. 
Transfected cells were incubated at 37°C and 5%C02 for 48 hours until lysis. 
Table 5. Small Interfering RNA Molecules Targeting Syntaxin 18 Used 
In This Study 
siRNA # 
siRNA 1 
siRNA 2 
siRNA 3 
siRNA 4 
siRNA 5 
siRNA 6 
Sequence (5' to 3' sense) 
GGAUGACAGACAGAACGtt 
GGAUGCCCAGAUAUUCAUGtt 
GGGAAGAUCAUAGUUAAUAtt 
CUUUGUAUUUGGUUCUGGUUCCAGCUU 
CUGGUCUAUCUGGUCUGUUCUGUGUC 
GAAUGUAUCUCCUUGUGAGCUUCUGUU 
Dicer 
Substrate 
No 
No 
No 
Yes 
Yes 
Yes 
Manufacterer 
Ambion 
Ambion 
Ambion 
IDT 
IDT 
IDT 
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Figure 20. A cartoon showing the coding region of the Stxl8 transcript and the 
target sites for each effecter molecule used in this chapter. Numbers in the brackets 
are the nucleotide where the siRNA molecule targets relative to the 5' end of the 
transcript. 
4.1.4. Transfections with RNase P-associated External Guide Sequences 
External guide sequences were design against predicted loop regions with the 5' 
end of the Syntaxin 18 transcript. The sequence of the EGS molecules can be seen in 
Table 6. The area of the Stxl8 transcript that each molecule is targeting is depicted in 
Figure 21. The pmU6 plasmids containing the EGS sequences were generated by 
Stanley Poon. The transfection of MCF-7 cells was done using Lipofectamine 2000 
reagent (Invitrogen) as previously described. An additional transfection was done 24 
after the initial transfection. Cells were incubated under the previously outlined 
conditions until protein or RNA extraction. 
4.1.5. Western Analysis 
Total protein extractions, protein quantifications and western analysis were done 
as describe previously (Section 2.1.5). 
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Table 6. The RNase-P Associated External Guide Sequences Examined in 
This Study. 
Molecule Sequence mRNA target 
EGS1 5'-GGCCGGCGUCAGCGCUCUA 5'-CGUCAAGACCGUGAAGACG-3' 
AUCCGAAUCCUUCCACGGUC 
ACCATTTTTAAAGGTACC-3' 
EGS2 5'-GGCCGGCUUGAGCGCUCUA 5'-CCGUGAAGACGCGGAACAAG-3' 
AUCCGAAUCCUUCCCGCGUC 
ACCATTTTTAAAGGTACC-3' 
EGS4 5'-GGCCGGUCUUAGCGCUCUA 5'-AUUCCGGGCCAGCGUCAAGA-3' 
AUCCGAAUCCUUCCGCUGGC 
ACCATTTTTAAAGGTACC-3' 
EGS2 C levage Site 
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Figure 21. The predicted MFold of the 5' coding region of the Stxl8 transcript. 
Arrows indicate the targeted cleavage site of each external guide sequence used in this 
aim. 
4.1.6. MTT Assay for Cell Survival 
For MTT assay over 96 hours, MCF-7 cells were plated into a 96 well plate using 
10000 cells and 200ul of growth medium in each well. 24 hours later, the cells were 
transfected using 0.5ul of Lipofectamine 2000 reagent and 0.5(xg of pmU6-EGS4 
plasmid. MTT measurements were taken as described in chapter 3 at 24, 48, 72 and 96 
hours following transfection. 
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For the MTT assay over 120 hours, MCF-7 cells were plated into 6-well plates at 
a density of 3x105 cells in each well. Cells were transfected as previously described. 24 
hours later, the cells were tripsinized and re-plated into a 96 well plate at a density of 
10000 cells/well. Cells were transfected a second time during the re-plating with 0.5ul of 
Lipofectamine 2000 reagent and 0.5ug of pmU6-EGS4 plasmid in each well. MTT 
measurements were taken at 24, 48, 60, 72, and 120 hours after the re-plating into 96 well 
plates. 
4.1.7. Isolation of RNA for Ribonuclease Protection Assay to Measure Steady State 
mRNA Levels 
MCF-7 cells were transfected in a 6 well plate with either pmU6 or pmU6-EGS5 
twice at 24 hour intervals as previously described. RNA was isolated 0, 24, 48 or 72 
hours after the second transfection using Trizol reagent as per manufacturers protocol 
(Gibco). Isolated RNA was quantified on a NanaDrop ND-1000 spectrophotometer 
(NanaDrop Technologies, Wilmington DE). Purified RNA was stored at -80oC until 
ribonuclease protection assay. 
4.1.8. Isolation of RNA for Ribonuclease Protection Assay to Measure mRNA Half-
life 
MCF-7 cells were transfected in a 6 well plate with either pmU6 or pmU6-EGS5 
twice at 24 hour intervals as previously described. 48 hours after the second transfection, 
Actinomycin D was added to the growth medium at a final concentration of 5u.g/ml. 
RNA was isolated 0, 5, 10, 20, 30, 60 and 120 minutes after the addition of Actinomycin 
D using Trizol as previously described. Isolated RNA was quantified on a NanaDrop 
ND-1000 spectrophotometer (NanaDrop Technologies, Wilmington DE). Purified RNA 
was stored at -80°C until ribonuclease protection assay. 
CHAPTER 4 - DOWN-REGULATING SYNTAXIN18 77 
4.1.9. Ribonuclease Protection Assay 
Ribonuclease protection assays were carried out according to the manufacturers 
protocol and as described in section 3.1.9. 
4.2. Results and Discussion 
4.2.1. Down-regulation Using Small Interfering RNA 
In order to examine the effects of silencing syntaxinl8 within MCF-7 cells, it was 
first necessary to develop an effective strategy to reduce the expression of syntaxinl8 to 
below normal levels. The first strategy investigated was RNA interference. It was felt 
that this strategy has the most potential for achieving knockdown due to its high success 
rate in other investigations. A total of six siRNA molecules were used, three designed by 
Ambion (siRNAl, siRNA2 and siRNA3) and three designed using SciTools RNAi 
Design tool from Integrated DNA Technologies Inc (siRNA4, siRNA5, and siRNA6). 
MCF-7 cells were transfected with the siRNA and 25p,g of total protein was examined by 
western analysis 48 hours following transfection. Small interfering RNA known to 
knockdown Homo sapiens GAPDH and p-actin transcripts were used as positive controls 
(30nM) while siRNA lacking homology to any known genes were used as negative 
controls. The results of these experiments can be seen in Figure 22. 
In examining Figure 22, it can be seen that all siRNA molecules investigated 
result in no observable reduction in syntaxinl8, while the positive control siRNA 
(GAPDH for Figure22-A, p-actin for Figure22-B) result in a clear reduction of their 
respective target protein levels. These data indicate that the transfection procedure was 
effective and that the fault most likely lies within the design of the siRNA targeting 
syntaxinl8. It should be noted that an increased transfection concentration of (lOOnM) 
siRNA 1-6 was attempted to examine whether these siRNA were less potent than the 
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positive control siRNAs; however the results of these experiments also showed no 
observable reduction of syntaxinl8 protein levels (data not shown). 
A B 
Figure 22. The expression of Syntaxinl8 in MCF-7 cells transfected with siRNAs 
designed against the Stxl8 transcript. (A) An immunoblot showing Syntaxinl8 and 
GAPDH protein levels in MCF-7 cells transfected with 30nM of siRNAs 1, 2 or 3 
designed by Ambion. (B) An immunoblot showing Syntaxinl8 and P-actin protein levels 
in MCF-7 cells transfected with siRNAs 4,5 and 6 designed in our lab separately and in 
conjunction. This figure is representative of three separate attempts. 
The design of effective small interfering RNA molecules can be challenging. All 
current design tools will generate a high number of predicted false positive siRNA 
molecules (Gong et al. 2006). It is therefore highly likely that although programs and 
established algorithms were used to generate these predicted siRNA sequences, they 
ultimately targeted areas of the syntaxinl8 transcript that were not optimal for the RNA 
interference and cleavage by the RISC complex. Initially, siRNA 1-3 were tested and 
generated no apparent knockdown. These molecules were conventional in that they were 
19-21nts long and could be directly used by the RNA-induced silencing complex to 
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facilitate knockdown. Current research suggests that longer siRNA molecules can act as 
substrates for Dicer. It is thought that Dicer has a role in introducing the siRNA 
molecule into the RISC complex. Thus, siRNA molecules that are first processed by 
Dicer are much more potent than those that bypass Dicer (Amarzguioui et al. 2006). 
Small interfering RNAs 4-6 were designed using the SciTools RNAi Design tool (IDT. 
2007). These were designed to be 27 nucleotides long in order to facilitate processing by 
dicer. However, as seen in Figure 22, these molecules were also ineffective in achieving 
knockdown. 
It is possible that some or all of the siRNA molecules were effective, only the 
syntaxinl8 protein persists due to its stable nature. If this was the case, then it is possible 
that 48 hours post transfection is too early to observe knockdown. In order to address 
this, and identical experiment was carried out, and the total protein was analyzed 72 
hours post-transfection. Unfortunately, this experiment also showed no observable 
knockdown of Stxl8 (data not shown). 
4.2.2. Down-regulation Using RNaseP-associated External Guide Sequences 
The second strategy employed to achieve knockdown was the use of RNaseP-
associated external guide sequences. Three EGS molecules were designed by Dr. Chow 
Lee to target the predicted loop regions of the syntaxinl8 transcript. The predicted Mfold 
structure of the 5' end of the Six 18 transcript, as well as the target cleavage sites for each 
RNaseP-associated EGS can be seen in earlier in Figure 21. Loop regions were targeted 
for endonucleolytic attack by RNaseP because these regions are exposed and more 
accessible by RNase P. 
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MCF-7 or SKOV3 cells were transfected twice, at 24 hour intervals with either 
pmU6-EGSl, pmU6-EGS2 or pmU6-EGS4 and 25ug of total protein was examined by 
western analysis 48 hours after the initial transfection. Empty pmU6 vector was used as a 
negative control in this experiment. The results of this experiment can be seen in Figure 
23. 
A B 
Figure 23. The effects of RNaseP-associated external guide sequences on Stxl8 
protein levels in MCF-7 and SKOV3 cells. (A) An immunoblot showing Syntaxinl8, 
GAPDH and (3-actin protein levels in cells MCF-7 transfected pmU6-EGSl, pmU6-
EGS2 and pmU6-EGS4. (B) An immunoblot showing Syntaxinl8, and P-actin protein 
levels in cells SKOV3 cells transfected pmU6-EGSl, pmU6-EGS2 and pmU6-EGS4. 
25 ug of total protein was used. Empty pmU6 vector and a non-transfected sample were 
used as negative controls. Cells were lysed 48 hours following the second transfection. 
Knockdown of Stxl8 with EGS4 was confirmed in another independent trial. 
Figure 23A shows that no knockdown was achieved using EGS1 and EGS3 
(Figure 23A, lanes 3 and 4). This is evidenced by the fact that all bands representing 
molecules with affinity for the anti-Stxl8 antibody within these samples show no change 
when compared to the samples that were not transfected or transfected with empty pmU6 
vector (lanes 1 and 2). However, cells transfected with pmU6-EGS4 appeared to exhibit 
detectable knockdown within the 35 (approximately 70%), 40 (complete knockout) and 
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45 (approximately 90%) kDa bands while no change is observed in the highest molecular 
weight 55kDa band (lane 5). Also, the expression of (3-actin and GAPDH appears to be 
similar between all lanes, indicating that the reduction of Syntaxinl8 in lane 5 is not due 
to loading error. 
Interestingly, some but not all of the bands exhibited knockdown when the cells 
were transfected with pmU6-EGS4. This suggests that the 55kDa band may be appearing 
as a result of non-specific binding of the 1° antibody. All other bands were affected 
indicating that they may be, at least in part, Stxl8. For example Stxl8 may be forming 
an SDS-resistant tertiary SNARE complex with another protein, which as been observed 
with other members of the SNARE family (Poirier et al, 1998). If Stxl8 was 
successfully silenced, then less would be available to complex with other proteins, and a 
reduction in both the levels of the monomer and the heterodimer might be observed. 
Also, as discussed in chapter2, Stxl8 may be post-translationally modified resulting in a 
multiple banding pattern on SDS-PAGE. If this was the case, then a knockdown in Stxl8 
protein would be expected to result in a reduction of multiple bands on the immunoblot. 
A knockdown experiment was attempted in SKOV3 cells using the external guide 
sequences; however, no significant knockdown was achieved (Figure 23B). This is 
contrary to what occurred within MCF-7 cells and may be attributed to the seemingly 
lower transfectability of the SKOV3 cell line with Lipofectamine 2000 reagent. In fact, 
as observed in chapter2 Figure 10, SKOV3 cells were transfected much less efficiently 
with pcDNA3.1/His/LacZ when compared to MCF-7 cells. It would be expected that an 
inefficient transfection would impair the ability of the EGS to silence a gene within a 
population, as many cells will not receive the EGS molecule. 
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It appears that RNase-P associated external guide sequence technology was able 
to effectively knockdown the levels of Stxl8 within MCF-7 cells. This strategy was used 
in subsequent goals of Aim III. 
4.2.3. Cell Survivability Assays 
Once a suitable method of silencing Stxl8 in MCF-7 cells was discovered, it was 
of interest to measure its effect on the survivability and proliferation of the cells using 
MTT assays. MCF-7 cells were transfected twice with pmU6-EGS4 and measurements 
were taken at 24 hour intervals following the second transfection. The results can be seen 
in Figure 24. 
In Figure 24, it is clear that there are differences between the cells that were 
transfected with the empty pmU6 vector (solid) and the ones transfected with pmU6-
EGS4 (dashed). Initially between 24 and 48 hours the two samples proliferated at the 
same rate; however, the cells with Stxl8 silenced exhibited slower growth than the 
control between 48 and 72 hours. After 72 hours, the cell population transfected with 
empty pmU6 vector began to grow more slowly whereas the cells expressing reduced 
levels of Stxl8 maintained a relatively constant rate of proliferation. 
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Figure 24. A comparative MTT assay showing the effect of down-regulating Stxl8 
in MCF-7 cells. MCF-7 cells were transfected with either pmU6 (blue) or pmU6-EGS4 
(red). Error bars represent the standard deviation of 4 independent samples. This figure 
is representative of three trials. 
It is not surprising that a reduction in Stxl8 results in a different rate of growth 
than normal. In yeast, it has been observed that a null phenotype of Ufelp, a homologue 
to Stxl8, is lethal. This is thought to occur through impaired retrograde transport 
resulting from lack of this protein (Lewis et al. 1996; Teng et al. 2001). One possibility 
for the slower growth observed in the pmU6-EGS4 transfected sample is that reduced 
Stxl8 levels results in impaired retrograde Golgi-ER trafficking. This might negatively 
impact cellular metabolism as important factors may not be recycling back into the ER 
efficiently due to poor uptake of trafficking vesicles into the ER membrane. 
Stxl8 has been known to associate with various proteins that can effect cellular 
division and survival. As reviewed in chapter 1 section 1.3.3, ZW10 and BNIP1 both 
associate with Stxl8 (Arasaki et al. 2006). BNIP1 is important to apoptosis (Nakajima et 
al. 2004) and ZW10 plays a part in cellular division (Hirose et al. 2004). It is possible 
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that a reduction in basal Stxl8 protein levels somehow affects the function of these two 
proteins resulting in slower cell division or increased apoptosis. 
If Stxl8 was actively cleaving the c-myc transcript, then a higher proliferative rate 
would be expected upon knockout of the suspected endoribonuclease. In fact, the 
opposite effect is being observed. This evidence does not seem to support the hypothesis 
of Stxl8 cleaving c-myc mRNA; nevertheless, this does not exclude the possibility that 
the SNARE protein acts as an endoribonuclease on other transcripts. It is possible that a 
lack of Stxl8 is resulting in the stabilization of another transcript and this might be 
contributing to the slower growth observed. 
As outlined in chapter 3, c-myc mRNA levels are increased in MCF-7 cells upon 
E2 exposure (Rodrick et al. 2005; Mawson et al. 2005). If a knockout of Stxl8 stabilizes 
c-myc mRNA, maybe this effect can be exaggerated if the levels of the c-myc transcript 
are increased due to E2 exposure. In order to investigate this, MCF-7 were incubated 
with E2 and insulin in order to observe differences in proliferation between the 
transfected and untransfected samples. The results of this experiment can be seen in 
Figure 25. 
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Figure 25. The effect of down regulating Stxl8 on cellular proliferation of MCF-7 
cells treated with 17-P-estradiol and insulin. (A) A comparative MTT assay showing 
the effect of down-regulating Stxl8 in cells grown in the presence of 17-P-estradiol and 
insulin. (B) A graphical representation showing the changes in cell density at each 24 
hour interval. Error bars are the standard deviation of 4 independent replicates. This 
experiment is representative of two separate trials. (*) ANOVA shows results to be 
significant at the p=0.01 level. (**) ANOVA shows the results to be significant at the 
p=0.05 level. 
Interestingly, the trend observed in this experiment seems to contradict what was 
previously observed earlier in Figure 24. Figure 25A shows a slightly higher 
proliferative rate in the cells that have Stxl8 silenced (dashed) when compared to the 
control population. Another representation of this can be seen in Figure 25B. Changes in 
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cell density between the 24 hour intervals are slightly higher in the Stxl8 silenced 
population until 72 hours is reached. However, at this point, a negative population 
growth begins to occur in both populations with the silenced population showing a much 
grater reduction in population relative to the control population. 
The slightly faster growth observed during the first 48 hours of this experiment 
might support Stxl8 acting as an endoribonuclease. Due to the E2, there is an increased 
level of c-myc mRNA within the cells. If the role of Stxl8 is to cleave the c-myc 
transcript and it is silenced, then more c-myc transcript might be stabilized, directly 
resulting in a higher level of c-Myc protein. This would contribute to a higher rate of cell 
cycle division in cells lacking Stxl8. After 72 hours, the silenced population shows a 
rapid rate of cell death. The reason for this may also be explained by an increased level 
of c-Myc. One group observed that a medulloblastoma cell line that was stably 
overexpressing c-Myc showed an increased rate of cellular division as well as an 
increased rate of apoptosis (Steams et al. 2006). Maybe as the 72 hour mark is reached, 
c-Myc protein levels begin to affect the rate of apoptosis. In the sample where Stxl8 is 
silenced, more c-Myc protein has accumulated, resulting in a greater rate of apoptosis 
when compared to the control sample. 
An alternative explanation for the high level of death after 72 hours is that the 
cells themselves are running low on resources and space within the plates. Since the 
Stxl8 silenced population was growing more rapidly initially, there may be more 
competition for the remaining nutrients, thus creating a more exaggerated decline in 
population compared to the control. 
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4.2.4. Ribonuclease Protection Assays for c-myc and p-actin 
In order to investigate whether a down regulation of Stxl8 resulted in a 
stabilization of c-myc mRNA, ribonuclease protection assays were employed. Initially, 
the steady state levels of c-myc mRNA at four time-points (0, 24, 48, and 72 hours) were 
compared. MCF-7 cells exposed to E2 and insulin were transfected with pmU6-EGS4. 
mRNA was extracted at each time-point and subjected to ribonuclease protection assay 
analysis. The results of this experiment can be seen in Figure 26. 
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Figure 26. Ribonuclease protecion assay showing the relative steady state 
expression of c-myc and P-actin transcripts upon knockdown of Stxl8. 20|ag of total 
RNA was hybridized to the either (3-actin or c-myc specific internally labeled probe. 
Digestion of unprotected fragments were carried out using RNaseA/Tl. Samples were 
run on a 6% denaturing polyacrylamide gel. 
By examining Figure 26, it does not appear that c-myc mRNA steady state levels 
are greatly affected by Six 18 knockout over 72 hours. There seem to be slight 
differences between in mRNA levels between lanes; however, differences between the 
Stxl8 silenced population (compare lanes 6-8 for p-actin, lanes 13-15 for c-myc) and the 
control population (compare lanes 2-5 for P-actin, lanes 10-12 for c-myc) appear to be 
c-myc 
P-actin 
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minor. One notable observation that can be implied for this figure is that both the {3-actin 
and c-myc levels appear to be lowest at the time of transfection (lanes 2 and 9). It is 
unclear whether this is due to loading error or there is simply less of each transcript 
before transfection. It is highly likely that the transfection itself has an effect of the gene 
expression of the MCF-7 cells but since the same trend is observed between the two 
treatments, it is unlikely that the increase in abundance of mRNA in due to Stxl8 
knockout. 
Another interesting observation is that the 24 hour time-point for both the j3-actin 
and c-myc transcript in the control sample (lanes 3 and 10) are represented by less intense 
banding than the samples where Stxl8 was silenced (lanes 6 and 13). As mentioned 
before, these differences may be due to loading; however, an alternate explanation 
supporting the hypothesis does exist. If knocking out Stxl8 ceases its ability to 
endonucleolytically cleave mRNA, then maybe we are observing a slight stabilization of 
each transcript. There are many different factors that contribute to mRNA metabolism, 
as reviewed in chapter 1, so the effect of Stxl8 knockout may be short lived and we 
observe a correction to normal levels relative to the control after 48 hours. 
It would be interesting to see if knockout of Stxl8 can stabilize the proteins and 
increase their relative half-life. An experiment was conducted to examine the effect of 
knocking out Stxl8 on the half-life of the /3-actin and c-myc transcripts. The results of 
this experiment can be observed in Figure 27. 
Actinomycin D has been used in mRNA half-life experiments to inhibit the 
transcription of mRNA so that degradation rates of existing transcripts can be measured. 
It has been dependably used to investigate mRNA degradation in many cell lines, 
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including MCF-7 cells that have been exposed to 17-p-estradiol (Bemasconi et al. 2000; 
Dubik et al. 1988). Figure 27 does not show significant differences in the stability of 
c-myc rnRNA between treatments. A gradual reduction in the c-myc band is observed 
over 120 minutes for both treatments, but the rate of degradation appears to be very 
similar between treatments. 
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Figure 27. Ribonuclease protection assay showing the effect of knocking down 
Stxl8 of the half-life of the c-myc and p-actin transcripts. Cells were transfected 
twice with pmU6-EGS4 or pmU6 empty vector. Actinomycin D was added to the sample 
48 hours following the second transfection. Total RNA was harvested after the addition 
of actinomycin D at the time-points specified. 
It does appear that the c-myc transcript is being degraded at a slower rate than 
expected in both treatments. It normally has a half-life of 18 minutes in MCF-7 cells 
(Dubik et al. 1988); however, it appear that a significant reduction of the band intensity is 
only observed at 60 minutes in the pmU6 treatment and 30 minutes in the pmU6-EGS4 
treatment. One possible source of this might be error in quantification or RNA 
precipitation recovery efficiency. Since the p-actin bands also exhibit different 
c-myc 
P-actin 
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intensities throughout, despite having a much longer half-life (10 hours) (Alberts et al. 
2004), this is a most likely explanation; although repeated experiments would be required 
to confirm this. In order to compensate with errors in loading, the relative intensity of the 
c-myc band compared to the (3-actin band in the same lane were compare. The results of 
this analysis can be observed in Figure 28. 
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Figure 28. Rate of c-myc mRNA degradation expressed as the relative intensity of 
the c-myc band compared to its respective P-actin band in Figure 27. Intensities of 
the bands were calculated using the OptiQuant program. The results are expressed as the 
proportion between the intensities of the c-myc and (3-actin bands. A linear regression 
analysis was preformed to generate the best fit line. 
From Figure 28, it appears that c-myc mRNA is being degraded much more 
slowly than expected. Although procedures were carried out using the same strategy that 
was used effectively in other studies (Bernasconi et al. 2000), there appears to be a factor 
delaying the effect of the Actinomycin D. Bernasconi et al did have one major difference 
from the strategy that was used here; they took fewer measurements with longer intervals 
between each one. It seems that their strategy allowed for the activity of Actinomycin D 
to take effect. 
CHAPTER 4 - DOWN-REGULATING SYNTAXIN18 91 
If Stxl8 possesses endoribonuclease activity in cells, then one would expect that a 
knockout of this protein would stabilize target transcripts. This does not seem to be the 
case. The parallel lines depicting each treatment in Figure 28 imply that there is no 
difference between the stability of c-myc mRNA when Stxl8 is knocked out. However, 
this does not exclude that Stxl8 might still cleave mRNA. The c-myc transcript is tightly 
regulated due to its role as a transcription factor; therefore it would seem plausible that 
redundant mechanisms exist to control its expression. Although it has been observed that 
Stxl8 possesses endoribonuclease activity in vitro (unpublished results), cellular models 
are much more complex. It is possible that transacting factors such as CRD-BP or cis-
acting elements within the c-myc transcript are preventing Stxl8 from cleaving c-myc 
mRNA. 
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Chapter 5 
General Discussion 
5.1. General Overview 
Endoribonucleases are increasingly being recognized as important factors in the 
control of mRNA expression. To date, several endoribonucleases have been 
characterized. These include enzymes that cleave the a-globin, c-myc, vitellogenin and 
albumin transcripts (Rogers et al. 2002; Wang et al. 2004; Tourriere et al. 2001; 
Cunningham et al. 2000; Yang et al. 2004) (reviewed in Tablel). Our lab has discovered 
a candidate endoribonuclease that has been shown to possess endoribonucleolytic activity 
in vitro (Bergstrom et al. 2006). This enzyme was tentatively identified as Syntaxinl8. 
The recombinant form of Stxl8 was generated and was subsequently shown to possess 
endoribonucleolytic activity against the CRD of c-myc RNA in vitro (unpublished 
results). These observations led to the hypothesis that Stxl8 may function as an 
endoribonuclease in vivo. 
Stxl8 belongs to a family of t-SNARE proteins and its primary function is in ER-
golgi trafficking (Hatsuzawa et al. 2000; Bossis et al. 2005). To date, there has been no 
evidence outside of our laboratory to suggest that it may also function as an 
endoribonuclease. The goal of this MSc thesis was to lend evidence either for or against 
the possibility that Stxl8 may function as an endoribonuclease in cells. Several factors 
were examined towards this end, including the effect of modulating Stxl8 expression on 
c-myc mRNA levels and half-life, and cell survival. This study has provided evidence 
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supporting Stxl8 having a role as an endonuclease in cells. There is also evidence 
showing inconsistency with this hypothesis. 
5.2. Examining the Expression of Syntaxinl8 in Multiple Cells 
Lines and Tissues 
While the primary aim of this thesis was to assess whether Stxl8 functions as an 
endoribonuclease in cells, screening of multiple cell lines for Six 18 was necessary to 
acquire a cell line that could act as an adequate experimental model. In screening various 
cell lines for Six 18 expression, it was found that all cell lines examined showed roughly 
the same level Stxl8 protein (Figure 7). The cell lines used were derived from multiple 
tissue types including breast, bone marrow, ovary, prostate and liver. There was also a 
cell line derived from peripheral blood (Table 3). This supports a ubiquitous expression 
of Stxl8 in most tissues as one lacking expression of Stxl8 has yet to be discovered. In 
addition, by searching the National Center for Biotechnology Information (NCBI) 
UniGene database for Stxl8 expressed sequence tags (EST), it was found that most 
tissues were found to express Stxl8 mRNA (data accessible at NCBI UniGene database; 
http://www.ncbi.nlm.nih.gov/UniGene/ESTProfile Viewer.cgi?uglist=Hs.584913). In 
fact, out of 50 healthy tissue types accounted for in the database, 31 were found to have 
Stxl8 ESTs present, including all tissue types probed by Western analysis in this 
investigation. Surprisingly, Stxl8 ESTs were not present in the normal bone marrow. 
This is in contrast to this study which showed Stxl8 protein in cancer cell lines K562, 
KGla and KGla200 (Figure 7). Differences between normal tissue and tumor derived 
cells lines might be attributed to the apparent up-regulation of Stxl8 expression that 
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occurs upon progression into a cancerous state, resulting in expression of the gene in the 
tumor derived cell line despite none being normally expressed. 
To date, there have been no reports in literature comparing the specific expression 
of Stxl8 between normal and carcinogenic tissues by Western analysis or 
immunohistochemistry. When the expression of Stxl8 protein in tumorigenic breast 
tissue was compared to normal breast tissue in this study, an increased Stxl8 protein 
level was observed within the cancerous tissues (Figure 8 and 9). Also, using micro-
array analysis Mecham et al (2004) reported an increased level of Stxl8 expression in the 
breast cancer cell line MDA-MB-436 compared to normal mammary epithelial cells (data 
accessible at NCBI GEO database, accession number GSM21254; 
http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc= GSM21254). (Mecham et al. 
2004). This data, combined with the results of the comparative Western analysis 
represented in Figure 8, and the immunohistochemistry staining represented in Figure 9, 
support the notion that Stxl8 is differentially expressed in normal breast tissue and breast 
cancer. It is possible that Stxl8 is up-regulated as a result of the increased concentration 
of transcription factors such as c-Myc, c-Fos or c-Jun that is often seen in tumors (Mai et 
al. 2003; Langer et al. 2006). It is currently not known if an increase in Stxl8 expression 
is essential for tumor progression or whether it is simply a consequence. Judging from 
this study and the observations made in the DNA micro-array analysis (Mecham et al. 
2004), it is tempting to speculate the former hypothesis. 
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5.3. Examining the Effect of Modulating Syntaxinl8 on Cell 
Survival and Proliferation 
If Stxl8 functions as an endoribonuclease in cells, then it would probably have an 
effect on the proliferation of those cells. This would especially be true if Stxl8 were to 
target and cleave the c-myc transcript. From the data observed in this investigation, it 
appears that modulating the expression of Stxl8 does impact proliferation of MCF-7 
cells, and this effect is exaggerated when the cells are stimulated with 17p-estradiol and 
insulin. 
This strain of MCF-7 cells was acquired from the American Type Culture 
Collection (ATCC) and has been shown to demonstrate sensitivity to E2 stimulation 
(Hamelers et al, 2003). This being true, there does appear to be differences between the 
cultures that were grown under normal growth conditions and those that were stimulated 
with E2 and insulin. Upon up-regulation with truncated Six 18, reduced proliferation was 
observed between 24 and 48 hours, after which the culture recovered and an increase in 
proliferation was observed between 48 and 72 hours (Figure 15A). While only truncated 
Stxl8 protein was observed to have an anti-proliferative effect on MCF-7 cells under 
normal growth conditions, upon stimulation with E2 and insulin, the full length Stxl8 
protein also demonstrated the ability to slow growth of MCF-7 cells (Figure 16). Also, 
the slowed growth persisted until 96 hours post-transfection (Figure 16). Similarly, when 
Stxl8 was down-regulated, a reduction in proliferation was also observed between 48 and 
72 hours (Figure 24); however, upon E2 and insulin stimulation a knockout of Stxl8 
seemed to allow for an increased growth rate until 72 hours post transfection. Between 
72 and 96 hours, the culture expressing reduced levels of Six 18 seem to exhibit reduced 
survivability (Figure 25). 
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It is clear that modulating Stxl8 has an effect on the proliferation of MCF-7 cells. 
There exist several possibilities in regards to the mechanism in which this occurs. One 
possibility which supports an endonucleolytic role of Stxl8 is that the protein is cleaving 
the c-myc transcript and slowing proliferation. This mechanism is supported by the 
increased effect of Stxl8 up-regulation (Figurel6) observed upon E2 stimulation. When 
MCF-7 cells are incubated with E2, a greater level of c-myc is expressed (Rodrik et al. 
2005; Mawson et al. 2005); therefore, c-myc driven proliferation is likely more 
prominent. In cells that are transfected with Stxl8 or the truncated version, c-myc mRNA 
may be cleaved at a greater rate, effectively reducing the proliferation of those cells. 
Also, when Stxl8 is knocked out in cells treated with E2, an increase in proliferation is 
observed for the first 72 hours, which might be due to bound Stxl8 being present to 
facilitate cleavage of the c-myc transcript. 
Another possible explanation involves the ER stress response and its possible 
effect on proliferation. Due to the localization of Stxl8 to the ER membrane (Hatsuzawa 
et al. 2000; Bossis et al. 2005), it is possible that modulation of this protein can elicit the 
ER stress response. In fact, up-regulating Stxl8 results in ER aggregation (Hatsuzawa et 
al. 2000), which may induce the ER stress response (Szegezdi et al. 2006) Also, ER 
stress has been shown inhibit cyclin Dl so that the cell is in cell cycle arrest until ER 
homeostasis is restored (Brewer et al. 1999). If up-regulation of Stxl8 is resulting in ER 
stress, a lower rate of proliferation would be expected. In order to confirm this 
hypothesis, ER-stress could be induced using a chemical agent such as thapsigargin, 
which causes and increase in the concentration of intracellular calcium, resulting in an 
accumulation of unfolded proteins (Song et al. 2002). If the cells subjected to ER stress 
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show a similar change in proliferation as the Stxl8 up-regulated cells, then this would be 
evidence supporting ER-stress as the likely cause of the slower proliferation in the cells 
expressing increased levels of Stxl8. Also, caspase-12 is an ER-stress specific caspase 
and can be used as an indicator if ER-stress induction through its detection in Western 
analysis (Mandic et al. 2003). Therefore, MCF-7 cells could be treated in parallel with 
thapsigargin or Stxl8 plasmid. If similar levels of capase-12 protein are observed in both 
cultures, then this would provide further evidence that ER-stress is being induced upon 
Stxl8 up-regulation. 
Another explanation may involve the interactions of Stxl8 with other proteins. 
Stxl8 has been known to associate with proteins that are involved in cell cycle 
progression (ZW10) and apoptosis (BNIP1) (Arasaki et al. 2006; Nakajima et al. 2004; 
Hirose et al. 2004). Therefore, modulation of Stxl8 expression might affect the function 
of these proteins and alter the proliferation or survivability of transfected cells within the 
culture. In order to test this, it could be possible to disrupt any interaction between Stxl8 
and ZW10 or BNEP1 by transfecting with antibodies specific to ZW10 or BNIP1 in an 
attempt to disrupt their interaction with Stxl8. Assuming that the protein-protein 
interaction was successfully blocked, the modulation of Stxl8 would have no effect on 
proliferation if the hypothesis were true, as Stxl8 would be unable to affect the function 
of BNIP1 or ZW10. However, it might be possible that the interaction of these proteins 
with their respective antibodies might results in changes in proliferation due to the 
disruption of ZW10 or BNIP1 by the antibody-antigen interaction. 
It may also be possible that the knockout of Stxl8 does not effect the proliferation 
of MCF-7 cells and the decreased proliferation under normal growth conditions (Figure 
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24), or increased proliferation under E2 and insulin stimulation (Figure 25) may be due to 
off-target effects of the RNase-P associated EGS. With technologies that facilitate the 
knockdown of a specific gene, including RNA interference or RNase-P associated EGSs, 
there is the possibility of off-target effects. These off-target effects have been known to 
occur when the effector sequence has a close, but imperfect match to a non-specific target 
sequence (Jackson et al. 2003; Lim et al. 2005). This facilitates the silencing of the non-
specific gene and may impact the reliability of results obtained from gene knockdown 
studies (Jackson et al. 2004). 
When running a BLAST search on the EGS4 sequence (Table 6), it was found 
that several human genes exhibited sequence similarity. Although only Stxl8 showed a 
100% match, other genes did show up in the search including an alpha chain of type IV 
collagen (Accession NM 001849.2, 75% query match), interferon regulatory factor 2 
(IRF2)(Accession NM 002199.2, 70% query match) or phosphatidylinositol-4-phosphate 
5-kinase, type II, beta (PIP5K2p)(Accession NM 138687.1. 70% query match). There is 
evidence to support IRF2 acting as an oncogene in human breast cancers (Doherty et al. 
2001); therefore, if this gene were knocked out, the proliferation of MCF-7 cells might be 
impacted negatively. Possibly, this effect is nullified upon E2 and insulin stimulation, 
resulting in the slightly higher proliferative rate seen within the first 72 hours of Stxl8 
knockdown. Also, PIP5K2b is known to be over-expressed in gastric cancer (Varis et al. 
2002), and therefore might contribute to an uncontrolled proliferative phenotype. If it is 
also overexpressed in the MCF-7 breast cancer derived cell line, the unspecific 
knockdown of this gene might negatively impact proliferation. It would be beneficial to 
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examine the levels of IRF2 and PIP5Kb after transfection with EGS4 to ensure that their 
expression is unaltered upon Stxl8 knockdown. 
It is apparent that modulating Stxl8 does impact proliferation. Changes within 
MCF-7 cells upon E2 and insulin stimulation appear to make the changes more 
pronounced when Stxl8 is up-regulated, and reverse the effect when Stxl8 is down-
regulated. Since E2 is known to induce the expression of c-myc mRNA (Dubik et al. 
1988), we might be observing the effect of Stxl8 cleaving and therefore reducing the 
levels of c-myc mRNA, resulting in altered proliferation. However, E2 and insulin can 
affect many changes within MCF-7 cells such as an increase in cyclinDl and cyclin E, or 
alter levels of cyclin dependant kinases p21 and p27 (Chappell et al. 2001; Dupont et al. 
2001), therefore, this does not definitively prove that changes observed in this study are 
due specifically to an interaction between Stxl8 and c-myc mRNA. 
5.4. Examining the Effect of Modulating Syntaxinl8 on c-myc 
mRNA Stability 
The proto-oncogene, c-myc is important to the area of cancer research. It has 
been seen to be up-regulated or amplified in virtually all types of cancer. Also, Stxl8 has 
been shown to cleave c-myc mRNA in vitro at the coding region determinant of the 
transcript (data not published). It is for these reasons that we decided to examine the 
effect of modulating Stxl8 on the stability of c-myc mRNA within MCF-7 cells. 
When examining data acquired for examining c-myc mRNA stability upon Stxl8 
modulation, interpretation is dependant on whether P-actin is able to act as an effective 
loading control. Assuming that modulation of Stxl8 has no effect on the level of P-actin 
mRNA, and it can therefore be used as an effective loading control, then it appears that 
the data does not support Stxl8 acting as an endoribonuclease. In examining Figure 19, 
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it is clear that when Stxl8 is up-regulated, changes in the levels of c-myc transcript are 
mirrored by changes in the levels of the P-actin transcript. This is indicative of 
differences between lanes being due to loading error rather then actual changes in the 
abundance of transcript. The same trend is observed when Stxl8 is knocked out (Figure 
26). Changes in c-myc transcript levels reflect changes in P-actin mRNA levels. 
Common controls for ribonuclease protection assays include GAPDH (Scott et al. 
1997), G3PDH (Rottman. 2002) and p-actin (Haendler et al. 2004). Therefore, it is 
reasonable to assume that P-actin is able to provide a standard in which to compare 
relative c-myc mRNA levels between samples. However, since we are dealing with an 
endoribonuclease, this might cause complications and compromise the reliability of the 
loading control. 
It has been observed that the partially purified native mammalian 
endoribonuclease that was tentatively identified as Stxl8 was able to cleave various 
mRNAs including c-myc CRD, [5-globin, MDR1, and the 5'end of the c-myc transcript 
(Bergstrom et al. 2006). If the endoribonuclease is capable of cleaving a variety of 
transcripts, it might also be able to cleave the P-actin transcript, despite its relative 
stability. If this were the case, then p-actin would not be an appropriate control, and the 
data would need to be interpreted differently. 
When Stxl8 is up-regulated, we see a reduction of -50% in both the c-myc and 
the fi-actin mRNA levels at 48 hours (Figure 19, compare lanes 7 and 8). Also, at the 
same time-point, we see an even greater reduction of -75% when the cells are transfected 
with truncated protein (Figure 19, compare lanes 7 and 9). Incidentally, at 48 hours is 
when the greatest level of recombinant protein is expressed (Figure 13B). If the data is 
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interpreted in this manner, then it supports the role of Stxl8 as an endoribonuclease. 
When Stxl8 was knocked-down, steady state c-myc mRNA levels did not appear to be 
greatly affected. There was a higher level (-50%) of both (3-actin and the c-myc 
transcripts at 24 hours in the cells that were expressing reduced Stxl8 levels (Figure 26, 
compare lanes 2 and 10 to lanes 5 and 13). This might be indicative of a slight 
stabilization of the transcripts at this time-point, but since all other time-points remain 
unaffected, this may be an artifact of loading. 
When Stxl8 was knocked down, and the half-life of the c-myc transcript was 
measured, it appears that no apparent difference was observed (Figure 27). When a ratio 
of c-myc mRNA to fi-actin mRNA was plotted, the rate of c-myc mRNA degradation was 
the same in both treatments. If Stxl8 were an endoribonuclease in cells, then a reduction 
in its levels should stabilize the transcript. This was not observed, but that does not 
disprove the hypothesis. A tightly regulated gene such as c-myc could possess back-up 
mechanisms or multiple pathways to regulate its expression. This data could be 
confirmed through the use of alternative transcriptional inhibitors such as cordyceptin or 
5,6-dichloro-l-p-D-ribofuranosylbenzimidazole (Loreni et al. 2000), and monitoring the 
degradation of c-myc; however, doing this would only serve to confirm the lack of effect 
down-regulating Stxl8 has on c-myc mRNA half-life. It would not distinguish whether 
the lack of change is due to alternate c-myc mRNA regulatory mechanisms or whether it 
is simply because Stxl8 does not act to cleave c-myc mRNA in cells. 
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5.5. Assessing the Role of Syntaxinl8 as an Endoribonuclease 
in MCF-7 Cells 
During the course of this study, evidence was acquired that could support the 
hypothesis that Stxl8 acts as an endoribonuclease. In contrast, some pieces of data seem 
to support the opposite claim that it does not affect the stability of transcripts. While up-
regulating Stxl8 does not alter the survivability of MCF-7 cells under normal conditions, 
when those same cells are stimulated with E2 and insulin, a reduction in the proliferative 
rate is observed. Transfection of MCF-7 cells with truncated Stxl8 results in lower 
proliferation whether the cells are subjected to E2 and insulin or not. Therefore, when c-
myc levels are higher, both the truncated and the full-length Stxl8 protein can affect a 
change in proliferation. 
Down-regulation of Stxl8 results in reduced proliferation between 48 and 72 
hours, while the opposite is observed during this interval upon E2 and insulin stimulation. 
If Stxl8 was cleaving the c-myc transcript, then the slower proliferative rate upon up-
regulation would make sense as more c-myc mRNA is being cleaved. Similarly, 
assuming that Stxl8 cleaves P-actin mRNA as well, we see reduced levels of c-myc 
mRNA when the expression of the recombinant protein is the greatest. Also, at 24 hours 
post transfection, we see more P-actin and c-myc mRNA in the MCF-7 cells where Stxl8 
was silenced; possibly as a result of an increased stability. This is assuming that p-actin 
is also being cleaved, or stabilized by Stxl8. However, in contradiction to the 
hypothesis, c-myc mRNA half-life is unaffected by a knock-out of Stxl8. Evidence for 
or against Stxl8 acting as an endoribonuclease in MCF-7 cells is outlined in Table 7. 
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Table 7. Evidence supporting or contradicting the role of Stxl8 as an 
endoribonuclease in MCF-7 cells 
Evidence supporting Stxl8 as an 
endoribonuclease 
1. Reduced proliferation upon up-regulating 
Stxl8 
2. Increased proliferation upon down-
regulating Stxl8 (+E2 and insulin) 
3. Up-regulating Stxl8 results in less mRNA 
present 48 hours post-transfection 
4. Down-regulating Stxl8 results in more P-
actin or c-myc mRNA at 24 hours post 
transfection 
5. Human Stxl8 was predicted to belong to an 
mRNA-binding family of proteins. (Cai et al. 
2005). 
Evidence contradicting Stxl8 as an 
endoribonuclease 
1. Decreased proliferation upon down-
regulating Stxl8 (in the absence of E2 and 
insulin) 
2. c-myc transcript levels are unaffected by 
Stxl8 up-regulation at all time-points 
(assuming P-actin as a loading control) 
3. c-myc transcript levels are unaffected by 
Stxl8 down-regulation at all time-points 
(assuming P-actin as a loading control) 
4. c-myc mRNA half-life is unaffected by a 
knockout of Stxl8 
A large portion of the evidence is dependant on the ability of P-actin to act as a 
loading control in the ribonuclease protection assays. Literature and experience suggest 
that p-actin is dependable in its role as a loading control. It has been used effectively in 
Western analysis (Bryce et al. 2005), Northern blots (Lui et al. 2002), real-time PCR 
(Burton-Wurster et al. 2005) and ribonuclease protection assays (Haendler et al. 2004). 
Therefore, it is reasonable to assume that it would be effective in this case. However, one 
could confirm the validity of the results by using a non-messenger RNA loading control 
such as 18S ribosomal RNA. 18S rRNA has been effectively used as a loading control in 
other studies regarding mRNA expression (Urbich et al. 2000) and might be a preferred 
option when examining a protein that may possibly cleave mRNA. 
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5.6. Endoribonucleases and Cancer 
Due to their ability to cleave RNA, it is possible that endoribonucleases have a 
role in the development or suppression of cancer. In fact, an endonuclease termed 
RNaseL has been linked to prostate cancer, where individuals exhibiting a mutation in 
this gene are predisposed to development of the disease (Silverman. 2003). The ability 
for ribonucleases to alter gene expression through post-transcriptional regulation of 
transcripts make them likely contributors to altered gene expression often associated 
with cancer development. For example, an oncogene cancer-associated Sm-like (CaSm) 
is an exonuclease that when over-expressed, alters cell cycle progression by reducing the 
levels of p21 transcript (Fraser et al. 2005). Fraser et al found that over-expressing 
CaSm resulted in lower levels of p21 mRNA and they speculated that this allowed the 
cells to bypass vital checkpoints and proceed through the cell cycle uninhibited. Also, 
they found knocking out CaSm resulted in increased levels of p21 mRNA which reduced 
the proliferation of the cells (Fraser et al. 2005). This is evidence that ribonucleases can 
contribute to cancer through their ability to interact with certain transcripts. 
The data obtained in this study demonstrate that Stxl8 might have a role in cancer 
due to its ability to alter the proliferation of MCF-7 cells. Also, it has been shown to be 
up-regulated in breast cancer cells and EST evidence and Western analysis suggest that it 
might be differentially expressed between normal and transformed tissue (discussed in 
section 5.3). Interestingly, up-regulating Stxl8 negatively impacts the proliferation of 
MCF-7 cells. It might be possible that it is actively cleaving mRNAs associated with 
oncogenes, such as c-myc, and genes associated with cell cycle progression. However, it 
is difficult to conclude whether Stxl8 has an effect on steady-state mRNA levels in cells. 
In order to answer this, it would be beneficial to do a global analysis of gene expression 
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using DNA micro-arrays. This way, one could determine which genes are being affected 
by modulation of Stxl8. By grouping affected transcripts with their associated pathways 
and functions, it would be possible to determine whether the changes in proliferation are 
likely due to endonucleolytic activity or indirect effects, such as ER-stress. 
It should be noted that while increasing levels of Stxl8 in MCF-7 cells resulted in 
slower proliferation, tumorigenic breast tissue was found to express high levels of the 
Stxl8. One would expect that if Stxl8 is able to cleave c-myc mRNA, it would act as a 
tumor suppressor gene and would therefore be unlikely to be elevated in cancers. This is 
consistent with the observation of slower proliferation upon Stxl8 up-regulation, but 
inconsistent with the observation of increase Stxl8 protein in tumorigenic breast tissue. 
The differences might be explained by differential gene expression observed between 
tissues and cell lines, which are likely attributed to different selection pressures and 
growth conditions between the in vivo growth of tumor tissues and laboratory cell culture 
conditions to which cell lines are subjected (Ertel et al. 2006). 
5.7. Concluding Remarks 
Due to the nature of the data produced in this investigation, the role of Stxl8 as an 
endoribonuclease in MCF-7 cells is questionable. There are various strategies that could 
be employed to further investigate this question. It would be beneficial to do a global 
gene analysis using DNA micro-arrays to determine which genes or groups of genes are 
affected by Stxl8 modulation. While doing this, we could also examine the expression of 
cyclin Dl and ER-stress related genes to examine whether ER-stress is being induced. 
This would have the other added benefit of determining whether p-actin levels are 
affected by Stxl8 modulation as well, further confirming the results obtained by 
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ribonuclease protection assay. Recently, another group has been able to down-regulate 
Stxl8 using RNA interference (Hatsuzawa et al. 2006). Therefore, results acquired using 
RNase-P associated external guide sequences could be confirmed with this siRNA. In 
addition, further evidence regarding mRNA levels could be acquired with the use of real-
time PCR analysis. One could use primers amplifying a different region of c-myc mRNA 
then the CRD targeted in this study to confirm that there is no change in the transcript 
levels between treatments. 
At the outset of this study, Stxl8 was tentatively identified as the mammalian 
endoribonuclease capable of cleaving the CRD of c-myc RNA. Since then, other proteins 
have been partially purified which possess the same endonuclease activity (unpublished 
results). This brings into question as to whether the original endoribonuclease is Stxl8. 
Nevertheless, recombinant Stxl8 was shown to cleave c-myc mRNA in vitro, but cells 
are a much more complex model. It may be that trans-acting factors interacting with the 
transcripts, or proteins that associate with Stxl8, prevent it from cleaving mRNA. It 
could also be possible that redundant control mechanisms and alternate pathways mask 
any effect that Stxl8 has on mRNA stability. Either way, it is clear that there remain 
many questions regarding observations made during this study. Although the role of 
Stxl8 as a SNARE protein functioning in ER-golgi trafficking has been well established, 
its role as an endoribonuclease in cells remains undefined and needs further investigation. 
XI 
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Appendix A. Statistical Tables for MTT assays 
Table 8. Statistical analysis for the MTT up-regulation experiment with E2 and insulin, Trial 1. 
This table was used to generate Figure 16. 
Cell Density (X104) 
pCMV-XL5 
Mean 
Standard Deviation 
24 hours 48 hours 60 hours 72 hours 96 hours 120 hours 
1.9 
1.99 
1.73 
2.04 
1.915 
0.13626 
3.55 
3.94 
3.47 
3.67 
3.655957 
0.20463 
5.62 
5.50 
5.56 
5.50 
5.543319 
0.061245 
7.59 
7.59 
7.33 
7.50 
7.499685 
0.121402 
15.67 
13.49 
14.79 
11.89 
13.95831 
1.646518 
10.84 
9.23 
9.33 
11.09 
10.12232 
0.980045 
pCMV-XL5Stx18 
Mean 
Standard Deviation 
pCMV-XL5Stx18dTM 
Mean 
Standard Deviation 
1.29 
1.86 
1.38 
1.51 
1.511071 
0.251626 
1.22 
1.29 
1.38 
1.29 
1.293268 
0.067283 
2.48 
2.63 
2.14 
2.40 
2.412549 
0.206535 
1.97 
1.88 
1.97 
2.07 
1.973469 
0.074201 
4.27 
3.98 
4.27 
4.27 
4.194614 
0.142362 
3.51 
3.85 
4.27 
3.85 
3.866288 
0.310457 
4.68 
4.57 
4.79 
4.62 
4.664586 
0.092052 
4.37 
4.73 
6.17 
4.79 
5.012231 
0.791542 
7.94 
8.13 
10.12 
9.33 
8.87998 
1.028665 
7.41 
8.04 
10.96 
10.23 
9.161518 
1.705393 
17.78 
16.41 
16.98 
14.13 
16.32413 
1.570801 
17.78 
19.72 
25.12 
17.38 
20.00097 
3.562285 
p-value (from AVOVA) <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 
Table 9. Statistical analysis for the MTT up-regulation experiment with E2 and insulin, Trial 
2. 
Cell Density (X104) 
pCMV-XL5 
Mean 
Standard Deviation 
pCMV-XL5Stx18 
Mean 
Standard Deviation 
pCMV-XL5Stx18dTM 
Mean 
Standard Deviation 
24 hours 
2.56 
2.87 
2.13 
2.55 
2.5275 
0.303795 
2.11 
2.02 
1.97 
1.99 
2.0225 
0.061847 
2.45 
2.11 
2.05 
2.13 
2.185 
0.179907 
48 hours 
3.02 
3.24 
3.14 
3.55 
3.2375 
0.226918 
2.04 
2.57 
2.17 
2.46 
2.31 
0.246712 
2.67 
2.23 
2.57 
2.88 
2.5875 
0.271093 
60 hours 
5.56 
4.22 
5.03 
5.52 
5.0825 
0.623451 
4.03 
4.27 
4.34 
4.17 
4.2025 
0.134505 
4.17 
4.45 
4.43 
4.13 
4.295 
0.168424 
72 hours 
6.98 
6.88 
6.88 
7.54 
7.07 
0.31686 
4.57 
4.62 
4.57 
4.44 
4.55 
0.077028 
4.72 
4.13 
4.57 
4.83 
4.5625 
0.307395 
96 hours 
13.27 
10.45 
15.76 
12.78 
13.065 
2.177499 
7.45 
10.23 
8.88 
9.33 
8.9725 
1.159838 
9.75 
9.23 
11.27 
9.33 
9.895 
0.943946 
120 hours 
13.45 
13.49 
11.72 
14.57 
13.3075 
1.178654 
14.57 
15.65 
17.78 
13.56 
15.39 
1.807484 
17.78 
19.26 
16.41 
19.72 
18.2925 
1.50336 
p-value (from AVOVA) 0.02 <0.01 <0.01 <0.01 0.01 <0.01 
XXIV 
Table 10. Statistical analysis for the MTT down-regulation experiment with E2 and insulin, 
Trial 1. This table was used to generate Figure 25. 
Cell Density (X104) 24 hours 48 hours 60 hours 72 hours 96 hours 120 hours 
pmU6 
Mean 
Standard Deviation 
2.30 
2.57 
2.58 
2.85 
2.574794 
0.224383 
5.13 
5.09 
5.01 
5.56 
5.19821 
0.245472 
9.02 
8.28 
8.30 
8.93 
8.631674 
0.397239 
11.25 
12.65 
12.22 
12.22 
12.08235 
0.593137 
11.17 
10.47 
9.89 
9.29 
10.20378 
0.804029 
7.55 
7.33 
7.46 
6.84 
7.295693 
0.317887 
pmU6-EGS4 
Mean 
Standard Deviation 
2.92 
2.97 
3.21 
3.16 
3.067939 
0.141513 
6.92 
6.78 
6.92 
6.56 
6.793621 
0.168615 
10.59 
11.17 
11.19 
11.22 
11.04393 
0.301663 
15.60 
14.79 
14.16 
15.31 
14.96386 
0.632137 
9.02 
9.27 
8.34 
9.33 
8.988341 
0.455372 
7.93 
7.85 
7.71 
8.17 
7.913057 
0.190913 
p-value (from AVOVA) <0.01 <0.01 <0.01 <0.01 0.05 0.05 
Table 11. Statistical analysis for the MTT down-regulation experiment with E2 and insulin, 
Trial 2. 
Cell Density (X104) 
pmU6 
Mean 
Standard Deviation 
pmU6-EGS4 
Mean 
Standard Deviation 
24 hours 
1.55 
1.89 
2.57 
2.30 
2.0775 
0.449249 
2.88 
2.69 
2.76 
2.92 
2.8125 
0.106262 
48 hours 
3.57 
3.57 
3.78 
3.55 
3.6175 
0.108743 
4.45 
4.92 
4.87 
4.62 
4.715 
0.220076 
60 hours 
7.34 
7.26 
7.78 
8.02 
7.6 
0.361478 
9.84 
8.28 
9.45 
9.02 
9.1475 
0.6683 
72 hours 
10.78 
11.23 
11.56 
10.96 
11.1325 
0.339743 
13.96 
14.23 
14.02 
13.98 
14.0475 
0.124197 
96 hours 
13.76 
14.00 
13.65 
13.92 
13.8325 
0.157348 
14.57 
15.43 
14.87 
14.23 
14.775 
0.508953 
120 hours 
12.88 
11.27 
11.98 
12.36 
12.1225 
0.677563 
12.02 
11.94 
14.27 
12.87 
12.775 
1.081866 
p-value (from AVOVA) 0.01 <0.01 <0.01 <0.01 0.01 0.35 
